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Pr obi elll 
In the course of psychological experimentation an investigator's 
attention i8 often focused on the speed of behavior. One need merely 
recall how often he has seen the phrases "response rate" or "fre-
quency of response, tt in his reading of the literature. SeldOl'l, how-
ever, has the pertinent research been interested in these measures for 
their own sake. Rather, they have been indicative of 80lIl8 other vari-
able such as habit streftlth, etc. 
A study involving temporal parameters of behavior or p~rseaal 
teapo on the other hand, is very much concerBed with these measures of 
speed of behavior or rate of movement for their own sake. It assWlles 
that theae measures, when taken on a person in the proper conditions may 
yield valuable information for a judgment or characterization of that 
person. 
Duportant here is the difference in the experimental situation in 
which the lleasures are obtained. Measurement of personal tempo all108t 
exclusively iBvolves a situation in which the subject ia responding at 
a naturral rate or at a speed which he finds comfortable. It seldom is 
interested 1n either a maximum or minillull rate. Further, the subject 
is expected to be free frOll distracting influences such as experimental 
variables. In oeher situations the prime concern is usually the asse88-
ment of an observed chanae in the rate of respondina produced by the 
introduction of an experimental variable. 
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U.ing this concept of per.onal tempo or close approximations, seve-
ral inve.tigator. have explored the area of rate of motor activities with 
the purpose of de.eribin, the domain ~n~ defining teaporal parameters of 
behaWior (Allport and Vernon, 1933; Rimoldi, 1951; Haley, 1963). 
Earlier research had proposed a sin,le ,eneral factor of personal 
tempo, but this monistic interpretation gave wa, to a pluralistic one 
as a result of the more refined and exhaustive studies of the authors 
cited above. The, defined several factors in their description of the 
domain of personal tempo and in man, eases, the results of one verified 
what had previously been found by another. 
On the basis, then, of faetors which these authors have found to 
provide a clear structure in the description of certain aspects of per-
sonal tempo with normal subjects in a drug-free situation, the present 
author hopes to observe and describe the changes that the factorial 
st~ucture mayor may not undergo when normal subjects are subjected to 
the influences of certain basie pharmacolOlical Alents. That is, the 
question is whether the .... te.t., which to a ,reat extent are factori-
• 
ally pure, will eerve to define the .... factors under various drug con-
ditions as under normal or control eoDditions. Stated in a slightly dif-
ferent lIl8IUler, the problem can be viewed as one of the "pet'1ll8nence" of a 
domain under different drug conditions. 
3 
The various agents employed are: 
1. Atropine Sultate .S mg. 
2. Chlorpromazine Hydrochloride (Thorazi~) 50 mg. 
3. Physostigmine Salicylate (Eserine) 2 mg. 
4. Dexedrine 5 mg. 
Besides a condition for each of the above four drugs, a placebo and 
a normal (no capsule administered) condition was included in the design. 
This meant that six separate tactor structures were obtained, one for 
each of the six conditions. The normal and placebo conditions will be 
compared with previous research, and the drug conditions interpreted in 
the light of the normal and placebo conditions of the study and also in 
terms of previously known effects of the various agents employed. 
The agents used in this research can be classified in the following 
manner: 
Sympathetic 
ParasYD!Pathetic 
Stimulants 
Dexedrine 
Physostigmine 
Depresdnts 
Chlorpromazine 
Atropine 
In summary, the specific aims of this research are to evaluate and 
compare the effect of specified pharmacological agents on experimentally 
defined and factorially identified variables, in terms of the basic fac-
tors that underlie the development of behavior in tbRe. 
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In any attempt to report the pertinent literature of a specific 
problem under investigation, it is necessary to carefully delineate the 
salient features of the research being consid~red so that the evidence 
cited can be of value both in the design, and later, in the interpret a-
tion and evaluation of the results. Prom the statement of the problem 
in the first chapter, such features can be seen to be threefold: the 
study of a domain of personal tempo, the effects of five (including pla-
cebo) experimental treatments on this domain, and the use of normal human 
subjects. The coincidence of these three features defines a problem for 
which literature of direct relevance is praetically non-existent. Several 
considerations make this statement more plausible. 
The variable about which this study pivots, personal tempo, is rela-
tively ~nexplored according to the literature. This is particularly re-
markable when one considers not only the potential implications of such 
study, but also the fact that tempo variables go so far in satisfying the 
stringent demands of scientific m2thodology. It is often said that the 
• 
obvious is overlooked in favor of the bizarre. Perhaps this is the case 
here, since measures of the obvious natural or comfortable rate of be-
havioraremore frequently overlooked for the maximal or miDtmal measures. 
Another consideration is a practical one, viz., that it i8 extremely 
difficult to obtain human subjects for drug research. Those that are 
available are generally found in vadou. hospitals, a fact which, in a 
s 
great majority of the cases, does not permit their use as normal subjects. 
This being the case, most of the pharmacological and even the psychophar-
macological research cited has been done either with- animals or abnormals. 
Further, two of the drugs being observed, atropine and physostigmine, 
are quite new to the field of psychopharmacology, and even with chlorpro-
mazine and dexedrine, the majority of the literature cited is based on 
results found when working with the mentally ~isturbed. 
On the basis of the above consideration, the paucity of research 
having di~~ct relevance is more understandable and the fo~ttbr this 
section becomes more definable. The literature pertaining to the area 
of personal tempo in human subjects in a drug fre.c situation will be 
given most extensive coverage. Then bE~sic pharmacological information 
concerning the various agents employed in the study will be presented • 
• 
This will be followed by a summary of the studies with drugs having the 
greatest relevance to the present research. 
The concept of personal tempo first makes its appearance in psycho-
logical literature in the work of Neumann (1913), Reymert (1923). Braun 
(1927), and Guttmann (1931). These psychologists together with Downey 
(1923). Prischeisen-Kohler (1933) and Wu (1934) tended to agree with 
the popular notion that there is a general unita~i factor of tempo ex-
p1aining the rate of bodily movements. This was done on the basis of 
different of.'grees of experimental evidence. Accocding to the Downey!:!.!.!.!. 
Te~rament profile, it is suggested that the rate of writing a given ex-
6 
pression is indicative of the general speed capacity of the individual. 
Frischeisen-Kohler proposed her generalized tempo on the basis of high 
intra-individual consistencies in tests of finger and foot-tapping and 
preferred metronome rate. Though the basis of this observation was only 
a few tests, she felt confident of her results and ~nt on to submit a 
biological or genetic explan8.tion for personal tempo. She did so on 
the basis of evidence she collected fram monozygotic and bizygotic twins, 
siblings, and persons not related. The first showed the greatest amount 
of similarity, the last, the least amount. Support for this finding may 
be seen in Monnier (1956) and Kastenbaum (1959) where a physiological 
basis for tempo in the nervous system was posited. 
Wu provid:d additional experimental evidence for the monistic in-
terpretation of tempo. This study involved aik tests, employing finger 
and f oct-tapping, count ing numer a18 and words, re adine, and obl3erving oc-
tagons. All correlations were positive with a median value of .875. 
This was interpreted as clear evidence that in each of the six specific 
tasks studied, the individual worked at his ~l characteristic rate or 
"personal te.mpo." The SaJae 26 perSQl1lii1 were testE:.d again in a situation 
where maximal rates were explored and here also the interc~rrelations 
were found to be all positive. This led the author to conclude that, 
though no theoretical "itt factor could be demonstrated, a "general 
phenomeonlt seemed to exist in the several tasks t in that ther .. w~.s .d-
ways an e.lement of cawmlnity between any two of the six tasks studied. 
By way of extension, then, a person fast in one task might be expected 
7 
to be also fast in others. 
This concept of a general tempo factor was not without its antagon-
ists. In fact. present opinion and the weight of the evidence seems to 
support a specificity or pluralistic interpretation of the domain of tempo. 
Lauer (1933) found little relationship between specific response rates in 
typical samplings of voluntary and involuntary rates. He suggested that 
any tendency for bodily tempos to vary together would hold only for habi-
tual responses, if at all. Similar evidence was offered by Poley (1937) 
who indicated that speed of reactions was conditioned primarily by speci-
fic environmental factors. His conclusions also favored a specificity 
interpretation. 
One of the most important and refined studies in the early work 
on tempo was the study of Allport and Vernon (1933). In their Studies 
12 Expressive Movement, they proposed that a basically stable and con-
stant individual style was reflected in both gesture and handwriting 
and that theories of specificity and identical elements are inadequate 
to account for the constancy obtained. They also suggested that mo-
tion was a reflection of personality dispositions. They concluded 
that there was no uniform psychic tempo which pervaded all activities 
and described three factors: 1) a verbal speed factor including 
reading, counting, and writing 2) a drawing speed factor including 
drawing on paper and blackboard with the hands and also foot drawing 
3) a rhythmic speed factor including tasks involving small muscle move-
8 
ment. 
The relationship between speed and personality is commented on by 
Kennedy (1930) who found a significant positive relationship between 
scores on the Army Alpba Test and a composite score of several speed 
performances only when a limited time was allowed for the intelligence 
test; when the time interval was unlimited, the correlations vanished. 
After the work of Allport and Vernon, Harrison and Deveno (1938) 
and Harri,on (1941) concur in the interpretation of the domain of tempo 
as lacking a unitary explanation. Harrison and Deveno conclude that, 1) 
the intercorrelation of speed measurements indicates no unitary speed 
trait which is characteristic of various spontaneous movements or motor 
adjustments of an individual and 2) individuals tend to perform at a 
fairly consistent rate from one time to another. Harrison. in his 1941 
article, disputes the idea of Lauer (1933) that habituation may be an ex-
planation of the general phenomenon in personal tempo. 
At this point in the history of the literature of personal tempo, 
tbe area could be characterized as one plagued by confusion. Operational 
definitions of tempo varied, terminology differed from study to study 
and the controversy of the monistic versus pluralistic explanation 
prevailed. Inspired by the coaposite approach of Allport and Vernon 
and the recent advances in the methodology of factor analysis and hoping 
to clarify some of the ambiguities of the tempo research, Rimoldi per-
formed his researcbwhieh he published in 1951~ Researchers partial to 
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a specificity interpretation had suggested that many of the studies having 
monistic conclusions were probably due to the limited number of tests of 
tempo employed. A larger and more varied battery, the ,luralists argued, 
would not reproduce the general phenomenon. This was one of the main 
• questions investigated by Rimoldi. He performed a factor analysis of S9 
tests using, as his description of personal tempo, the consistent temporal 
pattern adopted by individuals in any given task or related group of tasks 
which were performed at a rate natural and comfortable to the subject. An 
exception. of course, would be reaction time measures or those forbidding 
such an interpretation by their very nature. His battery represented a 
comprehensive range of psychological functions of and allied to tempo. 
The subjects were 91 males between 19 and 2S years old. 
The factor analysis revealed nine factors including speed of: large 
motion of trunk and litnbs f small movements t drawina with feet, drawing 
with hands, perception, re~ction time, and cognition. The second order 
analysis revealed four factors: speed of all motor activities, speed of 
perception, speed of cognition, and reaction time. 
On the basis of Rimoldi's study and the later verifying results of 
Haley (1963, 1965), factors were selected to be utilized in this study. 
To represent Rimoldi's large muscle movement factor, three tests were 
selected, vb:., arm swinging, arm swinging parallel and arm swinging 
sympetrical. Representing his small muscle movement factor are the fin-
ger tapping tests with both hands. The drawing of circles and lines 
10 
represented his drawing-with-hands factor. His speed of perception fac-
tor is represented by the reading of news test. Tests of preferred met-
roname rate and time estimation despite their lack of clear interpreta-
tion from the literature, were included because of their seemingly obvious 
• 
connection with the subject matter, compelling interest, and evidence from 
the study of Haley (1963). According to the design the author would ex-
,ect to recover these factors in the normal condition (the no-capsule ad-
ministered situation), and perhaps in the placebo condition. 
Haley's (1963, 1965) studies basically involve tempo variables while 
giving special emphasis to physiological correlates and time estimation. 
His important findings relevant to this research are his verification of 
the large and small muscle movement and drawing factors of aimoldi and his 
work with the time estimation variable. Accordina to his results, met-
roname rate and time estimation help to define separate factors. 
The important finding of Rimoldi of the high consistency of tempo 
over periods of time of varyina length is not an unique obser~tion. Haley 
(1963) found supporting evidence allo in his reliability measures. Wu 
(1934) likewise had reported reliability coefficients in the high .80's. 
Mishima (1951) had similar findings. He found that even the introduction 
of distracting influences had liftle effect. This is relevant to the 
research in that the introduction of drugs may be considered to be d1s-
tracting influences ~d that the reliability of the tests has been es-
tablished as very high. 
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1.he oonsistency of • tEnpo taak va. the IJIlbject matter ot the study 
of R.1.1Ioldi and Cabanlki (1961). The r.search involved tapping out patterns 
of dots -nlJllally' gl"Ollped. 1he aount of t1.me .. pent in tapping ea.ch pattern 
was linearly related to the number of dots in the pattern and the tira. 
between pattern. raaained a straight Une tuDot1on regardless of the II1ze 
or the patterns. This is interesting in the light of the pr.sent study, 
in that it the linear funotion of different 111 •• patterns holds they shou1d 
app.ar in th. sae factor. AlflO the legths ot inteZ"'Yus betwe. pattern. 
ot Yariou. al... Ihould define the .... factor lino. th.,- are a straight 
line funotion. Frai ••• (1946, 1956) reports a1lIi1ar tiad1ngs and propo ... 
that 111.0. is a 'egregating tr.ework rather than ground tor the 1'h7thmio 
unit •• 
On the baal. ot the tni.dence ava1labl., thlll. a speoit1oity or plur .... 
11at1c interpr.tation ot peracmal t_po .... the 1101". plaualbl.. Farther, 
R1Aoldi b.as shown good reaacm to link peroeption and cognition to tempo 
funotions. A study by Gator (19)4) has sugg.sted that t.po lU.7 have po.. 
tentia1in the diagnoal. of m_tal diNNers br I1.a Anding that large yari .... 
tiona in "agr •• able" •• tronome rate va. charaoteristio of pathology. 
Epileptio. wer. !omd to tap at a taeter rate than 1101'Ilal.. 111e.. t1nding. 
are, ot cour.e. e:x:pections to ih. highly oonalst.t pertoraanoe. ot noNals 
in t_po tunotion •• 
Also th. 11 teratur. b.a. INggested that the ob.erY .. '. attention lIhou1d 
not be di Terted troa the segregating tra...-ork ot allence .eparating pat.-
terned taapo tunctions. Frai ... (1964, 1956) and Riaoldi and CabanaJd. (1961) 
have Vied their Yuue in the under-+· ... ~ft60 ot ..... -"" l. 
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At tbi. point in the I'm .. a INBUl"T of the 1mpol'tant cb.araoter1ltios 
of "ach drug will be pre.ented. .l reoeat textbook of phartlttoology by 
Muss.. and B1rcl (1961) pl"O't'ided the aajori ty of intOl'llation found in the 
following paragraphs on the various agents. 
ltroSn! M!ate. U.S.P., B.P •• I.P. is a deprenant of the parasyapa.-
thetie neM'Otls syst_ or a cholinergio blook1ng agent. It block. the action 
of acet;ylabol1ne at the effector oell. or the n4Nl"Olld.aoular junotion of 
ti.sues md organ, (fIllOoth and oardiac musole. and gland.) 1Jmenat.d by 
the postganglionio cholinergio n .... es. Th .. efore, all :fUnotion. controlled 
by' these nerves are depressed. Heart rate is JIOre rapid, .-oth mu801e. 
are relaxed, seoretions of the eJa)crine gland. are checked, and the pupils 
of the eyes are dilated. It does not prevent the fcmuUon of acetylcholine, 
nor doe. it destroy it; rather it OCIIlpete. for c1t •• on the receptor cell. 
idlich aoetylcholine nOl'l1la.11:r e:xoi. tes in the propagation of itllplllsep. 
AtrOpine is one ot the most .ffective mtagonists tct the action of 
acetylcholine ot the belladonna group. Its effects are 1d..m11ar to tho.e 
obtained when the eym.pa.thetio ne1'TOUS .,-&bem is overactive or when epine-
phrin. 1. injected. 
1herapeutic do .. s of atropme are from • S to 1 mg. It etimulate. the 
oerebJ"al oort.ex and the mtdu118. Doses ot tberapeltt1c sise .eldOli have 
been found tG effeot ps,yohie iU.'l'lct.1.ons. 
Plgso$Im.1ne Salioylate, U.S.P •• R.P., I.P •• (iaer1ne Salio;ylat&) IItl-
lIlulates tho parat91npathetlc nervoull qat. (a ob~l1nerg1c agent). It 81Ill1-
latas the action or acetylehol1ne, 1h.e hOJ"lllOne ot the puasy&pathet1o nervous 
1) 
.,..st.. It aet. by'1Daot1vatiag obolia •• tera •• and pl"OloagiDg organ. and 
t.t.sue. imlervated by' obolia .. g1.o ftItl.... th. .tfect. _ted. &1". slowing 
of the heart, vasodilation, inoreaaect 1Dteat1nal aoti v1 ty', increa.ed glan-
• dular seer.Uon, ptlpil1817 oorurtrioUoJl, and P&1"al.y&t.s of &OOOI'IOdation of 
the e,y.. aaau do .. s •• &t.tiz. the .tfector oell. at the JqOJle'tU"al junc-
tion to the action of ao.tyloholiD.; hee., *e1.tal .11101. OODtl"aot •• 
... uaal dosag. 1. 2 mg. Overdo ••• oau •• aa:Pked weakn ••• , nau. ... , 
vm ting, and a slow pU... mood pr •• atre 1. lovered, br.athing 1. labored, 
9!l!mft!9!! !trdr'ochlor1d!. U.8.P. (Tlloru1a.) depr ........ trJIIPa-
thet10 neM'OU8 I5'.1sta oentrally. It depress •• the r.t:lcrttlu format1on and 
the profuse thalamio projection qat.. and c:t1Id.nilbea alertn.... A patient 
thus becoa •• 1... sansi t:1. ve to tl"oubl.8OlIle lid. tuations that would. oau.e _0-
tional. r.spon.... Ps,yohotio patient. are ulUlated against hallucinations 
and ten1f'ying tl1ght. of the 1lIagination. Chlorp1'Glll&Z1ne act. on the hyp0-
thalamus which 1. p~ responSible for the vasodilation of the blood 
ve.sel. and tall 1n blood pre.sure. Ms aotion or the hypothalau.. alao 
oaus •• a lowering of bod;y ttlllPel"atur. and the haul metabOlac rat.. It 
alao depr •• se. the ohemoreoeptor trigger zone in the medulla and prevents 
the nausea and vm ting oaused by oertain drags md di.ea .... 
ChlorprO!llas1ne alao blooks the neurohormone. 1ft the autonoad.o nervous 
, ..,stem and produoe. adrClol;rt1o (va8ltd11ation) aDd antiohol1nerg1o (anti-
14 
spo_adio-dry __ uth, etc.) effect. It al_ has an .tihiste1ft" action. 
Farther, it potentiates the action ot 1l&I'OOtics, .esthetics, and hJpnctios. 
'lbe lIOn •• al therapeutic dDsage 1. 2.5 age 4 u. •• a dq or 10 age to 
1 Gal daily. 
• 
Pst£;\ne '"lfaW' Dextra AlAphetam1ne SUlfa.te, U.S.P •• Dexampha.tara1ne 
Sulfate, B.P •• is a stimulant ot the appatbetic nervous qat_ hartng pri-
mary action in the oerebral oortex. It haa 11 ttl. or no aotion on the par1-
pheral nervous systeu and thus doe. not affect blood pre_sue. It 1s used 
1:0 ~b the a.PP&ti te and depresses the son.. ot smell and eweet taste. It 
gives rise to brl;hter spirits and inoreases the physical a.ativity of the 
patient. It 1. used therapeutioally as a plJ9Ohio stilllulant in depressed 
state.e 
The usual dosage 1. 5 age twic. a day. It inhib1 ts aminoxida8e, an 
anzyme tha.t tends to oxidize certain a:m1nePJ to aldehyde.. By lessening 
the pt"Oduot.1.on ot the aldehyde.. Wh1ab. apparently depr •• s tis •• r.spiration. 
ta. dftg Ilay' allov the braia to faotion at a higher degP" ot aot1 Y1 t7. 
1bis aeot1on aball ooaolud. with a brief' iBspeotion of the aTa.11able 
literature em the drag. and variable. relft'8Ilt. te tb1. _dy. 
Probably the mo.t rel.vant at.ng1. piece ot r ...... ch wu that p .. tOl'lled 
by CabaDsk:1 (1961). His d.sign did not inw1T. a taotor ltNotv. ooapariacm 
nor i:nvoln factor analysis at all and theretore di.tter. tr. the pr.s.t 
r •• earob. in this reapect. It involv._ two d:rugs, dexedr.l.a. and HUtown, 
only one or which 1s used in this atudy. ae d1d _ploy .... al testa 11m118l" 
to the on •• of the pr.s.t r ... arch. a. tcnmd sigld.t1omt ehang.s in the 
IS 
in the drawing of o1role. aad 1!'l1lar .. ta* under the 1nf'l.lI.enoe ot the st1-
JIIllant (dexedr1ae • .5 ag) aad in t.app1ng ta •• after the acildn1.trat1on of 
the traaquUiz..... Bow ...... th ... ohmge. w .. e net slgn1.t.loantl.7 p'eat.ezo 
than s1Jd.1ar ohqe. after adld.1d.art.raUoa of the placebo. ., no ciet1n1. te 
CODOlualon. were drawn. 
Leonard Uhr in PraS • .!U Bthanor (1960) r6views the reccmt 11 t.rature 
of dJo\1g attect. G1'l slaple ps,yahOllotor ta.s. Aaong the pertinent studie. 
KOl'lletak;y. Baphr1e.. and 1Yart. (1957) fCln1Jld increasing iapaiN_t und.er 
increaang aotmt. of ohlorpraaB1De _ s1Ilple pq<dtomotor test. acb a. 
:plll"R1 t rotor. '!he t1rllt two nthors tound aore pronounoed det101 ta on Ida. 
pIe pa;roh_oto1" ta •• tornorma1.. than tor lOhi30phrciO.. Lehmann aad 
Csank (1951) fCRmd. cibl.erproraazine to attect tapping ~ed in a diraot1on 
opposite to dext1'o-_phetaad.lle ftltate (dexedr1ne). 
In teras of the _coal balanoe of the nol'lUl indi vidu.a1, 1 t 1. interest-
ing to _te that Yino_t (19.55) tound that _all do ... of chlorpJ'GIU.z1ne 
given no1"lU1 abject. reau1ted. in "an 1ncr .... ot o..ta1n s1.gna a .... ed. to 
be indioator. of anxlety.R 
Sohnt4der and Co.tU •• (1957) found talcl8l'loie. toward increaaed. reaction 
U.e under ohlorproaastae. Bejab. Ikai. and c:Lare (19'1>. however. w1:th 
prooh10rp0ru1ne f01Uld ao dg:n1t1oaat ettect. on the a1apl. psyahOllOwr 
testa of their battery. '!he dosage was _all how.v.,.. Ba.rbr:1dge (1958) 
found ~. to p,I'Odaoe a deeraaant in kGT ~pp1ag. 
PQ'!le aDd. "re (1955) obs.."ed that aphetaa1ne produoed an early 
r.t..e 1n prot101_q on the SAM E11ttd1mesi.onal pu,:l'8I!1t teat. 
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Oh:r (1960) oonolude. OIl the baal.at hi. reriew of experimental md._ce 
w1:th norul. that ..,. .. al tr&JllllU1l1 .... , aoag whlch 1. chlo:rpJ'01U.Z1ne, 
:rath .. OCJlud.atetq lIlproy. pe:rtOl'll&1tO. 'tIl'ldet" .tr.... Th. point 1. that lt 
the teR1Dg al t.u&tlon w... a atr ••• preyold.Jlg 81:t1I.aticm, CIhl.orp:romazine u::r 
be pPeet.d to pJ'Ocluoe an 1ae:raMCl rate .t tapp1ng over a placebo ooad1 t10n 
tor u:.aple, lt there w... a:tfT mx1etT asllOO1ated with tak1ng the aapaule. 
M. ldea 1s _"e.ted br stelnbeg (1963) _. lIhe sq. that the depressant 
01" atiaulant oharaeteriatlo ot a dru.g OaD be JIOd1t1ed by on.'. payohologioa! 
o:rg&tr1.sat1en. 
It ... have bee acted that expe:r1aetal eri.d._c. has not. been o1ted. 
conoerniJfg atl"op1D. and. J)hTaoat1p1ne. 'lh1. 1. dne to the absenoe in the 
literatur. ot the effect. ot th ... drug. on normal hmun Itlbjec::ts in pay-
chOllOtor 01" related taaks. In tact moat entation. 1n the literature COD-
oern1Dg th ... drugs 1s baeed on aniDla1 r.search. 
10 att.pt Will be JI&d. to review the 11 teratur. of the pertinent drug 
ettect. on ad.JI.'s, but this aeetion Will be concluded with a report on 
~ .t.u.q with nt ..... c. lt invo1v.s t..po vuiable.. In Condon (1965). 
drag and no dng cond1 tions were COJIlpared tor a stimulant (Herevan) and. 
a tr8ftClV.1lizel" (I.4.br1l1J1l). 10 slgnifioant dittereno .. were cblen-ad betw .. 
ocmd1t1onl. 'lb.. d1l1OUsa1on _ggeated that em. explanation JI&7 11e 1n .th.. 
conld.at.oy of the t.po variabl •• that .MIled to be quite resistant to 
chang.. '!h. t1nd1ngs ot Cabanski (reviewed earlier ) with drug .trect. on 
ham _bjeots was e1ted as perhaps COl"l"OMrative evid._c. 
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As eta.ted. prftiou. to the rfti_ ot the related 11 teratu.re, the speo1f1c 
aim of th1. re.eareh 1. the stadT of the pe1'lUIlellCe of a speo1t1ed. cl-..1n of 
personal t.po ad.. the 1ntlllalCe of tCRll" p,,8l'JIacolog1cal AI.ta and a 
plaoebo. AI hal b.. ..-, the tactor 8J'.l&l.yt.1c appl"Oaoh 1. q'tI1 te aew 1ft 
the Rudy ot drug ettect. 01'l t.po. 
Method 
• SU,b3t!t.1 A. total ot ~v ",bjecJta, t. mal. and ten teale, hetw .. 
the age.ot tv_v-oae and th1!"t7-t1 ... e, without historr of pqoh1atr1o 
and/or ol1n1cal dt.'blr'bance. were etud1ed. '!he purpoae ot the age llm1ta.. 
tion was to avoid the COIIlplex: pqcholog1cal obange. due to ... turati01'l and 
ageing. All the au.bject. were stwl-.t.ot either hII10r college or graduate 
level. to obtain ~g_. toT with reapect to eduoat1cm. 'or their Ml"'lio •• 
1ft th1. re.earob aDd other testing OOl'lduotecl Gr1ng the ...... 110n., the 
_bjeota were ~erated. 1b1. l'eMUCh was part ot a larger project 1UP-
ported by the Pl,1'Qh1atrio Tra1D1ng and ReINl'ob Authority ot the state ot 
Ill.:1no1 •• 
At th1. point 1 t JlUat be adII1 tted that the lin ot the ample 1. DOt 
a. large a. Jd.ght be de&1l"ed.. How.,.., 1 t was reatr10ted bee .... ot t1naa-
cia! and other pract10al ooaad.deraticm.. Sa.oA P1"Obla. ... to b. tlU te 
c .. on in drug reM&Z'Oh with hwurl. lI1.noe -(ft'C a 0 .... &1 peru..al ot the 
literatve (1rIl. and Wapner, 1962; Linton and Lang. 1962; Hllp.I, Fon.,., 
anc1 Gate., 1963) wUl1nd1oatebhat the Ii •• 1. not atypictal. 
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InstrUinents 
As was indicated pr~viouslYf the battery of tests employed in this 
r.0sEE..rch ,,'ere for the most part, those that were highly loaded in the factors 
selected for investigation. In t.his sEction, the individual tests will be 
describ(:d C'.E to ccntznt end IUEthod of meaSUrE,tRent. The numbers associated 
",lith the various tests will be the identifying code numbers for the tests 
• 
throughout the ;nt ire papl~r. It should bf-. noted that these numbers do not 
necessaril y indicate the. order in \01hi ch the tests were admi.nistered. The 
order in \-Jhich each test was presented will be indicated st'paratE.ly for 
each test. 
Before any of these tests were administered, the following instructions 
were given: 
In this e.x:periment you wi 11 be given a setries .:>£ tas>u which yeu are 
to perform at the rate that is most comfortable for you. Before each per-
formance you will be giv(:m specific instructions which you are to carry out 
at your most natural spe~d. You will start a_ given signal and continue 
until told to stop. If at any ti.me the instructions are not clear, do not 
hesitate to ask questions. 
1. Reading - The subject was given an editorial clipped fpom a daily 
ne"ispaper and was insttucted ~hat he .,:ould be given a signal to begin. and 
that 'he was to .read at his customary rate until tolo to 3tOp. He W.'lS asked 
the last v..'ord that he read ,.ince the re8.ding {"as not done aloud. Since six 
different forms were needed to avoid familarity with the material lor later 
occurring sessions. the some coluw~ist's articles were selecte~ from six 
different issues to control in some way for style and readability. The 
columns were f.rom old issues to ai/oid the possibility of the subject's 
having just read the article in his morning paper. The mE;asurement was the 
number of words for a thirty second interval. The test was given first. 
2. Arm Swinging - At a signal the sllbject was asked to begin swinging 
his non-preferred arm at his side at a comfortable rate until told to stop. 
Measurement ,\las the number of complete cycles during a thirty second in-
terval. This test was presente.d fourteentil. 
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3. Arms Parallel - In this test the subject was asked to extend his 
arms out in front of him in a parallel fashion and keeping them parallel 
to swing them, again at a comfortable rate, from a point parallel to his 
left shoulder to the point parallel to his right shoulder and back through 
the same arc. Measurement: number of cycles in a thirty second interval. 
This test was given fifteenth. 
4. Arms Symmetrical - The sublject was instructed to extend his arms 
out to his sides, parallel to his .houlders and while holding them out-
stretched to swing them toward the center. touchiAg their hands, and to 
return them to the original position. This, of course, was to be done at 
his most comfortable or natural rate. Measurement: number of cycles per 
30 second interval. ~er: si.teenth. 
s. Circles - The subject was liven a blank sheet of 8 1/2 by 11 paper 
and was told to draw as .any or as few circles of any size in any position 
that he liked. Measurement: number of circles per 30 second interval. 
Order: seventeenth. 
6. Lines - The subject was in this ease asked to draw lines, as many 
or as few, of any length, in any position on the blank paper. Measure-
ment: number of lines in a 30 second interval. Order: eighteenth. 
7. Time R.eproduction - The experimenter waid "start," allowed 40 
seconds to pass and then said "stop." The subject was then asked to re-
produce this interval as exactly as he could by sayina "start, tt allowing 
what appeared to be the same time period to pass, and saying "stop. tt The 
subject was instructed not to couht or aske use of any cues. Measurement 
lenlth of interval reproduced in seconds. Order: nineteenth. 
8. Time Production - The subject was instructed to produce a 40 second 
interval by saying "start, tt allowing what appeared to be a 40 second in-
terval to elapse, and then saying "stop." Measurement: length of interval 
produced in seconds. Order: twentieth. 
9. Metronome - The subject was asked to adjust the weight of the pen-
dulum of a metronome until he found a preferred rate. Measurement: pre-
ferred number of beats per minute. Order: twenty-first. 
The remaining measures were obtained from separate tasks of tapping 
patterns of two, three, and four dots with both the preferred and non-pre-
ferred hands. The tapping of the p~ttern8 was done with either the index 
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or middle finger of the appropriate hand. The tapping was done either on 
or near a microphone which was used to record the tapping on tape. The 
tapping sound on the tape was later.transferred to polygraph paper by 
means of a Sanborn Polygraph. This made it possible to have a visual rep-
resentation of the patterns of taps and the intervals of silence between 
the patterns. Since both the polygraph machine and the tape recorder ran 
at a constant rate, the length (in terms of millimeters) of the patterns 
and silence intervals on the polYlraph paper would be linearly related to 
an actual measure of time occupaed by a particular pattern or silence in-
terval. The relationship between a measure of time and length (millimeters) 
can be expreslled. by a constant value. The determination of the constant 
would depend on the speed of the polygraph machine. provided the tape re-
corder was run at the same speed as during the testing session, and this 
was the case. The units of measurement used in all the following tasks 
were millimeters; and because of their linear relationship with the cor-
responding time measures. no information was lost nor were the correla-
tions effected in any way. However, a great deal of unnecessary calcula-
tion was avoided. 
It will be 8een below that each tapping task yielded two measures 
which have been treated as separate variables in the analysis. It is, 
therefore, a moot question which, oecurred first in the testing session 
but for identification and organizational purposes, the length of the par-
tiCUlar pattern measure was arbitrarily designated the prior occurring mea-
sure. 
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In all these tapping tasks, of course, the subject was instructed to 
tap at a comfortable and natural rate. 
10. 2P - This measure of the length of the two dot pattern was obtained 
from the two-dot pattern tapping task with the preferred hand. Measure-
ment: mean length in millimeters o~er a 30 second interval. Order: second • 
• 11. 2BP - Measure of the sileuce intervals between the patterns of the 
two-dot pa.ttern tapping task with the preferred hand. Measurement: mean 
length in millimeters for a 30 second interval. Order: third 
12. 3P - Measure of three-dot pattern with preferred hand. Measure-
ment: mean length in millimeters for 30 second interval. Order: fourth. 
13. 3BP - Measure of silence intervals between three-dot patterns with 
preferred hand. Measurement: mean length in millimeters over 30 second 
interval. Order: fifth. 
14. 4P - Four-dot pattern, preferred hand. 
in millimeters for 30 second interval. Order: 
Meas urement : 
sixth. 
mean length 
IS. 4BP - Silences between four-dot patterns, preferred hand. 
ment: mean length in millimeters for 30 second interval. Order: 
Measure-
seventh. 
16. 2PN - Two-dot pattern, non-preferred hand. Measurement: mean 
length in millimeters for 30 second interval. Order: eight. 
17. 2BPN - Silences between two-dot patterns, non-preferred hand. 
Measurement: mean length in millimeters for 30 second interval. Order: 
ninth. 
18. 3PN - Three-dot pattern, non-preferred hand. Measurement: mean 
length in millimeters for 30 seconds. Order: tenth. 
19. 3BPN - Silences between three-dot patterns, non-preferred hand. 
Measurement: mean length in millimeters for 30 second. Order: eleventh. 
20. 4PN - Pour-dot pattern, {lon-preferred hand. Measurement: mean 
length in millimeters for 30 second interval. Order: twenfth. 
21. 4BPN - Silences between four-dot patterns, non-preferred hand. 
Measurement: mean length in millimeters for 30 second interval. Order: 
thirteentb. 
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In order to maintain measures which would be comparable and to avoid 
artifacts of the scoring system confusing the analysis of the results, it 
was attempted to provide the same unit of measurement throughout. That is, 
all tests were scored in terms of units of performance per time in~erval 
with the exception of tests 7 and 8 and tests 10-21. These were scored 
in terms of time per unit of performance. The agns of tests 7 and 8 were 
reversed in the correlation matrix, since their factorial identification 
was not as well known as those from 10-20. These latter were expected to 
define two factors, one~r the even and another for the odd-numbered tests. 
The composition of these two factors was not expected to be shared with 
any other test in the battery 80 it was not deemed practical to reverse 
their signs. As presented in the various tables, then, all tests are 
scored in terms of units of performance per time interval, with the excep-
tion of tests 10-21, which represent time per unit of performance. 
The problem of test reliability is not an issue in the present research • 
• 
Rimoldi (1951) has undertaken a systematic exploration of the reXabilities 
of these tests and found that, for periods of from two to four weeks, the 
measures were highly reliable. The correlations ranged from a lower limit 
of .78, with many falling in the high .80's. This time interval is well 
within the range of any individual's testing in the present research. 
These results were reinforced by Haley (1963). 
Facilities: The entire testing program was conducted at the facilities of 
the Department of Medicine, Stritch School of Medicine, Hines, Illinois, 
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under the medical supervision of Dr. Peter Talso, Internist and Chairman 
of the Department of Medicine. Each subject was given a physical examina-
tion to determine the advisability of his participation in the program, 
both for his own and the experimenter's protection. The normal (no capsule 
administered) and placebo conditions were also administered in these faci-
lities to maintain a constant experimental setting for all conditions or 
treatments. 
Drugs: The following were the pharmacological agents and the corresponding 
dosages employed in this research: 
1. Atropine Sulfate .5 mg. 
2. Chlorpromazine Hydrochloride (Thorazine) 50 mg. 
3. Physostigmine Salicylate 2 mg. 
4. Dextro-amphetamine Sulfate 5 mg. 
These agents and dosages were determined by consultation with the experts, 
Dr. Alexander Karczmar, Chairman of the Department of Pharmacology, and 
Dr. Peter Talso t Internist and Chairman of the Department of Medicine 
(both o£ fue Stritch School of Medicine). Tbey provided information as to 
the administration of the agents, the length of their optimum effect, and 
prescribed instructions for the subjects as to their diet prior to the 
testing. It was through their suggestions that provision was made in the 
testing schedule so that no subject would be tested twice within a three-
day period. The purpose of this was to avoid possible contamination of 
• 
the effects of a given drug by one administered too recently. 
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The dosages were selected so as to produce an optimum effect in contra-
distinction to a panalyzing effect. Optimum effect is here considered to 
be the effect of the usual therapeutic dosage. This latter dosage was 
preferred to larger ones or those more likely to produce dramatic changes 
because of the necessity of avoiding paralyzing effects. Such effects, 
would either completely incapacitate performance on the psychological tasks 
or seriously restrict their sensitivity to distinguish the effects of the 
various agents. Further, since the normal therapeutic dose is the most 
frequent treatment, it was considered quite important. 
The drugs and placebo were administered in capsule form. All capsules 
were of the same size, shape, and color, and otherwise lacked distinguishing 
characteristics. The administration of the capsules was done in a double-
blind fashion - neither experimenter nor subject knew the contents of the 
capsule. Also the subject was not told the identity of the agents employed 
until the conclusion of the entire program 
Experimental Design: The design called for six testing conditions, one 
for each of the four drugs, a placebo condition, and a normal (no capsule 
administered) condition. The entire battery of tests was administered 
during each condition. 
The presentation of the six conditions was accomplished in a systematic-
randomization fashion, i.e. each condition was presented approximately three 
times first, three times second, three times third, and so on through all 
six possible orders. Thus twenty (since there were twenty subjects) unique 
orderings of the six conditions were established such that all conditions 
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appeared approximately the same number of times in all the six orders. 
Since there were twenty subjects, it was, of course, impossible to estab-
lish a design allowing each condition to appear exactly the same number of 
times in each order. The number of subjects would have to be some multiple 
of six to ?ermit this. At any rate. no condition appeared more than four 
times and less than three times in any given order. The twenty orderings 
or presentations were matched randomly with the twenty subjects. 
This design was necessary to prevent the obscuring of the effects due 
to th~ drugs. by the effects of learning and practice. which were variables 
to be considered in the tests of intelligence. etc., which composed the 
rest of the project conducted during the same sessions. From the point of 
view of the tempo tests themselves, practice or learning effects could 
safely be ignored, considering the simplicity and general familiarity of 
the tasks involved. However, a serial effect due to the same order of 
presentation of the various conditions might conceivably have been present 
without this design. to influence the results both of the tempo and other 
variables tested in this project. 
No irudividual testing session went beyond the period of time specified 
by the experts as the optimum effect period for the various drugs empoyed. 
This means that the testing was not begun before the drugs were considered 
to have reached their optimum effect nor was the testing concluded after 
the optimum effect periOd had subsided. 
Upon the conclusion of the testing phase, the data was collected by con-
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dition. The intercorrelations of the twenty-one measures were performed for 
e8.ch condition by means of the 1. B.M. 7094 computer. This same computer 
was used to factor analyze each of the six conditions according to the 
principal aXeS solution. 
'nle factor analytic technique is obviously i.ndicated in research which 
calls for the comparison of various domains. Not so obvious, however, is 
the rationale for the exclusion of a tre.atm~nt 'Which would test for mean 
differences between crucial conditions on various variables. Of prima.ry 
interest is a change in structure or domain from one condition to another. 
This information cannot be interred from the results of mean tests of 8i&-
nificance. It is possible, for instance, for the means to be significantly 
different but for no change in factorial composition to be observed. It 
is likewise possible that no difference may be found between the means 
but a change is noted in the factorial composition. This situation pro-
bably would occur more frequently than the former. At any rate, there 
is no necessary connection between a significant change in means and a 
change in factorial composition. With reference to this same. question, 
Eysenck (1961) formed the conclusion that the only approach to drug 
studies which can give psychologically meaningful info~ation is the 
• 
factorial or dimensional approach. While this statement may be open to 
criticism because oftts extensiveness and generality, the present author 
thinks that it may have been instances such as the present research which 
prompted his remark. For these reasons mean tests of significance will 
not be presented; however, for those readers who may wish them, the means 
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and standard deviations will be presented in the Appendix. Tables 38 and 
39. 
The problems of communalities was handled in this way. Particularly 
with reference to determining the best communality estimates. factor analy-
ses of the six conditions were run with unity in the diagonals. This. of 
course. meant that not only common factors but also specific and error fac-
tors would be obtained. These factor solutions were then inspected with 
the purpose of determining the common factors. A decision as to their num-
ber was made on the basis of three criteria: 1) the value of the eigen 
value associated with a given factor 2) the percentage of variance ex-
tracted 3) an inspection of the factor loadings with a view toward re-
producing the correlation matrix. On these bases the number of common fac-
tors was estimated for a given problem. and on the basis of these factors 
communalities were computed. These latter values were seen to agree quite 
well with a simple estimate based on the maximum correlation of a column. 
At this point the factor analyses were repeated with the diagonal values 
being estimated according to the maximum ur" criterion. The computer was 
programmed to continue factoring until all the variance had been eatracted. 
These factor solutions were then checked in terms of their ability to re-
produce the original correlation matrices, i.e. final residual matrices 
were computed. These residuals indicated that the estimates of communality 
(maximum "rtf) and therefore the factor solutions were in excellent harmony 
with the original data as represented in the matrices of correlations. 
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In this way the orthogonal factor solutions for each of the six con-
ditions were obtained. Por the purposes of psychological interpretation, 
it was then necessary to rotate each orthogonal solution to the criterion 
of simple structure. Oblique hand graphical rotations were then taken in 
each condition until the closest possible approximation to simple struc-
ture was obtained. 
A comparison of the final oblique solutions was then undertaken. In-
volved in this comparison of factors from different conditions was an in-
dex,called, by Tucker, a coefficient of congruence, or, by Burt, an unad-
justed correlation, or, by Wrigley and Neuhaus, the degree of factorial 
similarity, as reported by Harman (1960). This measure was used to assess 
the degree of relationship between a given factor of one condition and all 
the factors from another condition. This measure will then be useful in 
describing the permanence of the domain under study from one condition to 
another. 
Results 
Due to the large volume of results to be reported, it is expedient to 
indicate the rationale behind their order of presentation. The first part 
of this section will consist of the presentation and interpretation of the 
six factor structures, condition by condition. The first structure analy-
zed will be that of the normal (no capsule administered) condition. This 
will be followed by the analysis of the placebo condition. Next in se-
quence will come the drug conditions; of these, those expected to have 
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similar effects because of their pharmacological characteristics will be 
presented successively. That is, the order will be parasympathetic de-
pressant (atropine), sympathetic stimulant (dexedrine), sympathetic de-
pressant (chlorpromazine), parasympathetic stimulant (physostigmine). 
Follouing the separate analysis of each condition will be the second 
part of this section, viz., the comparison of the structures of those 
conditions where interesting and meaningful information .ay be forthcoming. 
The comparison of this concluding part will be accomplished by means of 
the coeffic~nts of congruence mentioned in the previous section. 
In order to maintain uninterrupted presentation of the text as much as 
possible, pertinent tables are placed in the App~ndix. Thus, the inter-
correlations of the twenty-one measures for each of the six conditions can 
be found in Tables 8-13 of the Appendix. Tables 14-19 contain the unro-
tated principal axes solutions for the six conditions. Tables 20-25 pre-
sent the final transformation matrices for the various conditions. Tables 
26-31 contain the corresponding cosine matrices. Tables 32-37 present 
the final oblique rotated factor matrices for the six conditions. In all 
the above cases, the order in each set of tables will follow the presen-
tation of the conditions in the first part of the text. Thus, all infor-
mation pertinent to the factor analysis of the normal condition can be 
found ,by inspecting Tables 8, 14, 20, 26 and 32. In the interpretation of 
the various factors only values with an absolute value greater than .30 
will be considered. 
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Normal Condition 
Six factors were extracted in this condition. Of these six, one was 
seen to be a specific factor and the other a doublet. As shown by the 
factor loadings of the final oblique matrix, the structure is veJ:"Y clear 
and quite compelling, the factors being very clearly indicated. The let-
ter designation used to identify the fattors in this and the other condi-
tions is strictly arbitrary nomenclature and in no way affects the inter-
pretation of the structure or its comparison with other structures. 
Factor A 
Tests Loadings 
19. 3BPN .74 
13. 3BP .69 
15. 4BP .65 
11. 2BP .64 
21. 4BPN .64 
17. 2BPN .56 
Without exception, the measures defining Factor A are those of the 
length of the silence intervals separating the various tapped patterns of 
both the right and left hand. Both Fraisse (1956) and Rimoldi and 
Cabanski (1960) stressed the importance of these silence intervals as 
more than an accident of the tapping procedure. Both suggested that these 
silence intervals are the segregating framework for the various size pat-
terns. The silences undoubtedly form a necessary part of the rhythm with 
which the patterns are tapped; but this factor confirms their importance 
beyond this mere fact and certainly qualifies the study of them in their 
own ri ght. Their influence seems to be independent of the handedness of 
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the subject and, at least for patterns up to and including a$ize of four 
taps, independent of the length of the patterns involved. In fact, Rimoldi 
and Cabanski (1960) found evidence which indicated that the silence inter-
vals remained of constant length for the various pattern sizes. Thus, it 
seems that though the length of the silence interval is positively related 
to the pattern as seen by an inspection of the correlations and by noting 
the cosine of -.52 between the reference axes of the two hyper-planes in-
volved, two separate factors are needed to explain the motor activity in-
volved in the normal condition.* 
Pactor B 
• 
Tests Loadings 
5. Circles .76 
6. Linee .66 
7. Time Reproduction .64 
10. 2P .33 
This factor is obviously the intended replication of Rimoldi's (1951) 
drawi~ factor. Somewhat unexpected is the appearance of the Time Repro-
duction measure. The interpretation here seems to be that one's experi-
ence of the passage of time seems to be involved in his speed of drawing, 
i.e., those "impatient" with the passage of time (those who tend to give 
an underestimatem their reproduction of a given interval) demonstrate 
this impatience by drawing at a faster rate (more of a given unit in a 
given period of time). The inclusion of the measure of the two-dot pat-
tern in this interpretation is difficult to see; it especially seems worthy 
* A negative cosine for the reference axes of the two hyper-planes indi-
cates a positive relationship for the hyper-planes involved and vice-
versa. 
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of little note since the loading is low and since more of the other pattern 
measures make an appearance. This factor is quite unrelated to the other 
factors in the normal condition as seen in Table 26 of the Appendix. 
Factor C 
Tests Loadings 
16. 2PN .19 
12. 3P .71 
18. 3PN .77 
20. 4PN .77 
14. 4P .76 
10. 2P .68 
This factor is clearly a speed of tapping factor. called by Rimoldi (1951) 
• 
the small muscle movement factor. It is quite evident that this factor in-
eludes both right and left hand initiated patterns and involves patterns of 
different sizes. This was expected from the results of Rimoldi and Cabanski 
(1960) where the lengths of patterns of different numbers of taps were linear 
ly related to the number of taps in the pattern. It is interesting to note 
that this hyper-plane is seemingly negatively related to the specific factor 
for reading ratt>. Factor F. the cosine being .51. The negative is an arti-
fact of the scoring system since the patterns were measured in terms of time 
per unit. while Reading was measured by umits per time. The positive rela-
tionship is even more strongly suggested by Rimoldi (1951) who suggested that 
the oculomotor movement in reading may explain the relationship. 
Factor D 
Tests 
4. Arms Symmetrical 
3. Arms Parallel 
2. Arm Swinging 
7. Time Reproduction 
Loadings 
.86 
.82 
• S5 
.32 
33 
This factor clearly defines what Rimoldi (1951) called the large mus-
cle movement factor. The three tests with the high loadings are typically 
this type of movement. If the loading of test 7 merits interpretation in 
this factor, it may suggest that persons "impatient" in their experience 
of time (a tendency to underestimate an interval in its reproduction) may 
tend to swing their arms at a faster rate. It is interesting to note that 
this hyper-plane and the small muscle movement hyper-plane are practically 
perpendicular, suggesting that perhaps two entirely different mechanisms 
are involved in the two types of muscle movement. 
Factor B 
Tests 
9. Metronome 
8. Time !foduct ion 
Loadings 
.59 
.54 
This factor, obviously a doublet, suggests that one's estimate of the 
passaged time when instructed to produce an interval of a given length, 
is closely allied with what one experiences as a pleasing or comfortable 
rate of metronome beating. In other words, one's time estimation in the 
above sense, may tend to depend on how fast he would like time to pass. 
Factor F 
Factor F was a specific factor of reading speed, with a loading of .55 
and as such does not form part of the cammon factor space. 
From the description of the various factors of the normal condition, it 
is readily apparent that the factors introduced into the study on the basis 
of the previbus findings of Ri~oldi (1951) and their verification by Haley 
I , 
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(l963) have been recovered intact. The tests of time estimation introduced 
because of their compelling relevance to the area, have been the cause of 
some interesting possibilities. 
Haley (l963) did not observe any relationship between the three measures 
of subjective time used in this study as was found in Factor E. However, 
he did note that certain psychomotor activities were related to time esti-
mation measures and this has been observed also in this condition. 
Placebo Condition 
Seven factors were extracted in this condition. Of these, the last, 
Factor G, is clearly a residual factor. This factor was a centroid ex-
tracted by hand primarily for purposes of clarification in the biradial ro-
tation procedure. One of the remaining, Factor F, is the same doublet that 
was encountered in the normal condition in Factor E. Factor E in the pla-
cebo condition, though it appears to be a doublet, is very likely the sp~ 
cific reading factor reported in the normal condition. Again the structure 
is very clear and definite and each of the factors are very well indicated. 
Factor A 
Tests Loadin!s 
3. Arms Parallel .16 
4. Arms Symmetrical .69 
2. Arms Swinging .40 
This factor is obviously the large muscle movement factor .efined by 
Rimoldi (195l) and verified by Haley (l963). This factor is defined in 
this condition very similarly to its definition in the normal condition. 
The only difference in composition is the absence of Test 7, Time Repro-
duct ion, in this condition. Its loadings was quite low (.32), however, 
in the previous condition. 
Factor B 
Tests 
14. 4P 
16. 2PN 
20. 4PN 
12. 3P 
18. 3PN 
10. 2P 
Loadings 
.74 
.74 
.74 
.72 
.61 
.65 
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This factor is obviously a redefinition of the speed of tapping or small 
muscle movement factor found in the normal condition. The factor seems to 
be equally well defined in this condition and the same conclusions as to 
hand€dness and pattern size apply also here. In this condition also the 
eosin£' (-.64) reveals a positive relationship b€tween thi.s factor and the 
silence interval factor to be identified below. 
Factor C 
Tests Loadings 
S. Circles .78 
6. Lines .61 
7. Time Reproduction .58 
9. Metronome .42 
Again it is apparent that the factor is clearly defined and that its 
composition is quite sim.Har to the normal condition. The factor is the 
drawing speed factor of Rimo1di (1951) and Haley (1963) with the additional 
implication of the time reproduction test. This finding duplicates the 
results found in the normal condition. However, also in this factor is 
the Metronome test. Certain difficulties are encountered here in attempt-
ing to explain its presence. As seen in the normal condition, Metronome 
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and Time Production combine to form a doublet and here it is observed that 
Metronome is found in th£.' same factor with Tim.: Reproduction. This does 
not vitiate the previous interpretation but merely seems to indicate that 
the Metronome measure is a quite complex one as far as its factorial make-
up is concerned. The interpretation that might be offered here is that a 
preferred rate of metronome beat may also be involved in one's estimate, 
in terms of seconds, of an unknown interval of time given to him. Or, in 
other words, the implication seems to bE: that if one tends to prefer a fas-
ter beat of the metronome, he would tend to look on a given interval as 
passing more quickly and tend to underestimate its length. Preferred met-
ronome rate may be such a diverse measure that it is involved in both Time 
Production and Tin~ Reproduction despite the fact that the latter t~ are 
• 
not found in the same factor and do not have any common variance. Rimoldi 
(1951) found basically a metronome doublet, but his lines drawing~st had 
a low loading in the factor. This may have been a hint of what has been 
seen here. However, his battery did not involve any time estimation mea-
sures so no comparison is possible. Haley (1963) did have Metronome and 
time estimation measures, but his findings were negative with respect to 
any relationship between them. 
Factor D 
Tests Loadinis 
21. 4BPN .69 
IS. 4BP .64 
19. 3BPN .60 
13. 3BP .58 
17. 2BPN .56 
11. 2BP .52 
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Factor D very pointedly shows this factor to be the silence interval 
factor discussed previously in the normal condition. It has exactly the 
same composition as Factor A in the norma.! condition. This Factor D as 
noted above in the connection with Factor B, shows a positive relationship 
between speed of tapping (Factor B) and the silence interval (Factor D). 
Thes it has been seen that in both the normal and placebo conditions a 
two-factor explanation of the tapping task is indicated. The two factors 
are not independent, but the rotational procedure wa~ clear in indicating 
the two-factor interpretation. 
Factor E 
" Tests 
• 
I . Reading .54 
7. Time Reproduct ion .32 
This factor is very similar to the specific reading speed factor found 
in the normal condition with the exception of the rather low loading in 
the Time P~production task (.32). It is questionable whether this factor 
should be interpreted as a doublet b~cause of the low loading and the op-
posing evidence from Factor F of. th~ nonnal cond5.tion. 
Factpr F 
Tests 
8. Time Production 
9. Metronome 
Loadine 
.52 
.45 
This factor is a doublet which had been found previously in Factor E 
of the normal condition. An interpretation was suggested there. Finding 
a recurrence of this doublet in the placebo condition suggests very strongly 
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that its appearance in the normal condition is more than accidental. Or-
dinar:i..ly; the principal b£'.nefit of a doublet findl.ng is to suggest further 
research in this particular area. Its double occurrence seems to make this 
exhortat ion all the more urgent. 
Facto!' G 
This factor is seen to be a residual factor with the highest loading 
being .39, and all the other loadings being lower than .30. 
Prom the description and interpretation of the various factors of the 
placebo condition, it can be seen by means of inspection that thete is a 
• high degree of similarity between it and the normal condition. Specific 
measures of the degree of the relationship between the various factors will 
be presented in the last part of this section. However, it does not seem 
premature at this point to suggest that the administration of the placebo 
haa produced very little change in the structure as it was found under 
normal conditions. That is t the domain remains quite permanent from the 
normal to the placebo situation. 
Atropine Condition 
In this condition six factors were extracted and only five will be in-
terpreted since Factor F is residual. No specifics were noted as will be 
evident from what follows. Basically the same factors have been extracted 
here as in the previous conditions w~th slight variations in the composi-
tion of some of the factors. It might help to recall. at this time, that 
atropine is a depressant of the pacasyrupathetic nervous system. 
Factor A 
Tests 
18. 
16. 
10. 
12. 
1. 
20. 
14. 
2. 
3PN 
2PN 
2P 
3P 
R.eading 
4PN 
4P 
Arm Swinging 
Loadings 
.61 
.59 
.57 
.54 
-.54 
.53 
.46 
.42 
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Six of the eight tests in this factor give reasonable assurance that 
this is the small muscle movement factor observed before. In this case. 
howevEr. the rate of reading test and Arm S,]inging emerge also as part of 
this factor. This suggests that atropine has cmnged somehow the nature 
of the two tasks such that tbeir factorial composition is altered. With 
respect to R.eading, the following seems plausible. A known effect of 
atropine is the dilation of the pupil of the eye. This would definitely 
affect the ability of the person to read. Dilation of the pupil causes 
blurred vision and thus more fixations would seem to be necessary. This 
would seem to increase the necessity of the use of the muscles controlling 
the eye. It is suggested, then, that the activity of reading more nearly 
resembles the tapping movements. Perhaps the reading rate reverts to a 
more authmatic level. The negative is an artifact of the scoring method 
so the relationship is positive. 
With regard to the .42 loading of Arm Swinging, the first consideration 
is that despite the positive nature of the loading as presented, when view-
ing the measures from the aspect of the metbod of scoring. the loading sboul 
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be considered to be negative. In terms of its interpretation as part of 
this factor, it would seem that under atropine, arm swinging rate is nega-
tively related to rate of tapping or small muscle movement. The appear-
ance of the arm swinging task in the small muscle movement factor may be 
partially derived from the observation of~e experimenter that at times 
the subject seemed to swing just the forearm rather than the whole arm. 
This seems to indicate that shoulder and trunk muscles were not involved 
in the task. The ~egative relationship is difficult to interpret. 
Factor B 
Tests Loadings 
S. Circles .75 
6. Lines .74 
7. Time Reproduction .31 
Factor B seems not to have been affected by atropine. These three tests 
also defined the comparable factor in the normal and placebo conditions. 
Drawing speed and its relationship to Time Reproduction seems not to have 
been disturbed by the administration of atropine. 
Factor C 
Tests 
3. Arms Parallel 
4. Arms Symmetrical 
2. Arm Swinging 
Loadings 
.91 
.85 
.55 
This factor of large muscle movement has been found in practically 
identical forms in the normal and placebo condition. This suggests that 
atropine has had little or no effect on large muscle movement. at least as 
far as the f ac,torial composition is concerned. 
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Factor D 
Tests 1.oadi98 
8. Time Production .68 
7. Time Reproduction .60 
9. Metronome .60 
This factor is quite interesting. From the standpoint of structure it 
is clearly defined. This factor is composed of the three measures most 
commonly referred to as estimates of subjective time. Under the two-no-
drug conditions (normal and placebo) and in the study of Haley (1963) such 
an emergence of these three tests in a single factor failed to appear. 
That is, there is no evidence that both time estimates are in\O 1 ved with 
what is experienced as a pleasing beat of the metronome. Atropine seems 
to be responsible for this event. Just how this occprs is impossib1eto 
say. But this finding does shed some light on the discussion concerning 
whether time estimation is internally or externally ~gulated. Some have 
said that external cues alone should be considered. In the present re-
search these were reduced to a minimum, and the subject was instructed to 
avoid making Use of any cues. If this attempt was successful, only d18-
turbances of the interaal chemistry and related mechanisms would be in-
volved. This may mean that though external events can certainly affect 
time estimation, the possibility of something like a "cerebral rhythm" or 
"internal clock" should not be ignored. 
Factor E 
Tests 
15. 4BP 
13. 3BP 
1.oadinJs 
.66 
.63 
19. 33PN 
11. 2BP 
17. 2BPN 
21. 4BPN 
.59 
.56 
.54 
.54 
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Clearly defined in this factor is the silence interval composite that 
was recovered with the same component tests in both the normal and pla-
cebo conditi~ns. There was some probl~m in the oblique biradial rotations 
involving this factor and Factor A. The cosine indicating the angular 
separation of the reference axes of these two hyper-planes was dangerously 
high. Some consideration was given to the likelihood that perhaps the hyper-
planes should be identical and that only one factor was needed to explain 
the silence intervals and the tapping of the patterns. This alternative 
was tried in the biradial rotations and the separation of the two factors 
was judged preferable. Further evidence for the separation of the two 
factors came from the application of the single-plane method of rotation 
which showed a separation of the hyper-planes. Pinally, s.n oblique plot 
was made to eliminate distortion and two definite separate clusters were 
observed. Thus. though the factors involved were obviously highly related, 
two separate factors best explained the data. Therefore t in the a.tropine 
condition. the structure may be said to be more oblique than in the nor-
mal condition. 
Factor F 
This fllCtor will not be. interpreted since it is a resi.dual factor. 
To briefly summarize the atropine condition, it seems that the drug had 
the greatest effect on the factorial composition of Reading, time estima-
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tion tasks and Metronome. The obliqueness of structure seemed to be in-
creased. These would be things bo be carefully observed in any other fac-
torial research with the drug. 
Dexedrine Condition 
Dexedrine, it should be recalled, is a stimulant of the sympathetic ner-
vous system. Its effects should, then, be somewhat similar to those of at-
ropine which is said to block parasympathetic action. For this reason, the 
two conditions were consU1ered successively. 
This condition, of thoee discussed so far, is certainly the one which 
has exhibited the greatest change in structure. Six factors were extracted. 
Fac:tor • 
Tests Loadings 
12. 3P .94 
14. 4P .91 
13. 3BP .88 
16. 2PN .88 
10. 2P .81 
18. 3PN .86 
20. 4PN .84 
II. 2BP .82 
15. 4BP .79 
11. 2BPN .79 
19. 3BPN .77 
21. 4BPN .73 
7. Time Reproduction .44 
one glance at Factor A is enough to assure one that this factor is a 
combination of the silence interval and small muscle movement factors, 
which have been recovered singly in previous conditions. Now, therefore, 
the tapping seems to be no longer linearly independent of the silence in-
tervals. The one seems to be a function of the other. Sincl' such seems 
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to be the case, the previous importance of the silence intervals as a seg-
regating framework. therefor~ an active contributor to the experience of 
rhythm. may no longer hold. Possible corroboration of this is the obser-
vation of the experimenter, that in certain instances. no patterning seemed 
recognizable. especially in the four-dot patterns. If such were the case, 
this would certainly explain the chllapsed two factors in all other con-
ditions into one in the dexedrine condition. Dexedrine has repeatedly been 
observed to increase the activity level of the subject. If this is the case, 
it is reasonable to see how a sense of rhythm may be decreased in a hyper-
active subject. 
The same rotational problem which was observed in the separation of the 
two factors in the atropine condition was also observed in this condition. 
Only in this case the resolution of the dilemma was in the direction of a 
single factor explanation. The weight of the evidence .uggested this solu-
tion. Both the oblique plot and the single plane favored the single fac-
tor eaplanation. Also the biradial plots were cleaner in the single factor 
solution. 
The loading of the Time Reproduction task should be interpreted in the 
light of a negative loading because of the difference in scoring with the 
other measures. The interpretation indicates that perhaps the hyperactive 
person thinks that more time has passed than actually has. That is, the 
more active he is, (the faster he taps and therefore the lower the value 
he would have in measures 10-21). the longer he would tend to reproduce a 
given interval. The reason may be that he looks on the silent period as 
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having represented too great a waste of time and therefore, exaggerates its 
duration in his reproduction of it. 
Pact or B 
Tests 
3. Arms Parallel 
4. Arms Symmetrical 
2. Arms Swinging 
Loadings 
.89 
.79 
.37 
The large muscle movement factor obviously has been little affected by 
the administration of dexedrine. 
Factor C 
Teats Loadillis 
-
S. Circles .83 
6. Lines .13 
9. Metronome .41 
10. 2P .35 
The drawing speed factor with the presence of Metronome was observed 
also in the placebo condition and therefore, cannot be considered an unique 
effectd dexedrine. The presence of the measure for the tapping of the two-
dot pattern with the preferred hand shall not be interpreted because. of the 
absence of any other tapping measure. 
Factor D 
Tests Loadings 
l. Reading .41 
10. 2P -.36 
15. 4BP .35 
21. 4BPN .33 
16. 2PN -.32 
In the opinion of this author, if this factor is anything more than a 
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residual factor, it would be a specific factor of reading. However. the 
interpretation of it as a residual factor seems preferable. 
Factor E 
Tests 
1. Reading 
8. Time Product ion 
7. Time Reproduction 
Loadinls 
.6S 
.62 
.30 
This factor seems to relate one's subjective estimate of the passage of 
time with his reading rate. Further, it may be hazarded that the in~reased 
level of activity due to dexedrine haa speeded up the "internal clock" such 
that reading is performed faster than had been learned and also that time 
is experienced as moving faster. The other measure of subjective time, 
Metronome, is notably absent from this factor. Since the Metronome task 
is a measure of preferred time, it may mean that this hyperactivity is not 
a pleasant experience for normal subjects. 
Factor r 
Teats 
9. Metronome 
7. Time Reproduction 
2 • ArmS Swinging 
12. 3P 
Loadi9s 
.54 
.44 
.44 
.31 
In view of the three tests composing this factor, an interpretation is 
extremely difficult. Metronome and Time Reproduction have occurred together 
in Factor C of the placebo condition and Factor D of the atropine condition, 
but never in conjunction with Arm Swinging. Any reason why these three 
.hould define a factor as an effect of dexedrine is 4ifficult to surmise. 
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In summary, the large muscle movement factor and the drawing composite 
remain fairly resistant to change through all the conditions tested. Atro-
pine increased the relationship between the small muscle movement factor 
and the silence interval, and dexedrine increased it to such an extent that 
they could no longer be considered separate factors. On the bases of these 
results, it seems that the usual therapeutic dosage of dexedrine has a greater 
disruptive effect on the domain of tempo under study than the usual thera-
peutic dosage of atropine. 
Chlorpromazine Condition 
Chlorpromazine, or Thorazine, is a sympathetic depressant and as such 
sho~ demonstrate antagonistic effects to those of the previous two drugs. 
Seven faetors were extracted; however the last is clearly a residual fac-
tor and Factor E seems to be a specific. 
Factor A 
Tests LoadingS 
19. 3BPN .63 
17. 2SPN .57 
15. 4BP .55 
13. 3SP .54 
21. 4BPN .51 
11. 2BP .47 
8. T~e Production -.38 
Factor A is very elearly defined and straightforward in interpretation. 
It is the silence interval factor found in the normal condition with the 
addition of the Time Production test. Thus in this factor as one tends to 
overestimate the given interval, he also tends to lengthen the interval bet-
ween patterns. It is logical to accept the occurrence of this event in the 
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chlorpromazine condition since this drug has been known to slow tapping 
rates. 
Factor B 
Tests Loadings 
12. 3P .73 
18. 3PN .71 
10. 2P .67 
16. 2PN .67 
20. 4PN .65 
14. 4P .57 
The small muscle movement factor is obviously recovered intact in the 
ehlorpromazine condition. 
Factor C 
. 
Tests 
3. Arms Parallel 
4. Al~ symmetrical 
2. Arm Swinging 
Loadings 
.70 
.69 
.51 
The large muscle movement factor likewise seems to undergo no change as 
a result of the administration of chlorpromazine. 
Factor D 
Tests 
5. Circles 
6. Lines 
9 • Metronome 
Load illj s 
.62 
.56 
.43 
The factor of the drawing speed compo.ite with the presence of Metronome 
was noted in the placebo condition. There it was suggested that a pleasing 
experience of time as ~presented by the beat of a metronome is reflected 
also in the rate of drawing. Chlorpromazine thus seems to have no unique 
effects on this factor either. 
Factor E 
This appears to be a specific factor for metronome rate. 
Factor F 
. 
Tests 
1. Reading 
7. Time Reproduetion 
~adings 
.59 
.47 
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This doublet was also noted as 8 possibility in the placebo eondition. 
It may be suggested that the faster one reads the fastftr he would experience 
time to pass such that he would tend to underestimate a given interval when 
attempting to reproduce it. No unique effect of ehlorpromazine can be 88-
serted here either. 
Faetor G 
Factor G is a residual factor extracted for the purposes of clarifica-
tion in the rotation proeedure. 
It is evident from the foregoing that thlorproaazine brought about very 
little if Any change in the domain of tempo under study. A possible explana-
tion for tb.is ma.y be that the subjeets were subjected to a certain amount 
of stress beeause of a gDneral fear of the experimental situation. In such 
a ease, a sympathetie dominanee would very likely result. Chlorpromazine 
may have only served to restore balance to the organism. Thus, what amounted 
to a nonnal eondition may have resulted in the ehlorpromazine eondit1on. If 
sueh a s~tuational sympathetic dominance existed prior to the administration 
of any drug, it would tend to be heightened by agents stimulating the sym-
so 
pathetic n~rvous syst~, or the equivalent. This could serve to explain 
the comparitively greater changes seen in the inspection of the dexedrine 
condition. This matter will be taken up again in the comparison of the 
various conditions by means of the coefficients of congruence. 
Physostigmine ~~~ 
Physostigmine. or Eserine. is a stim~11ant of the parasympathetic ner-
vous system and may therefore be expected to behave similarly to chI or-
promazine. 
Six factors were extracted. Of these. one was a specific factor. 
Facmr A 
Te.sts Loadings 
20. 4PN .67 
18. 3PN .66 
HS. 2PN .57 
14. 4p .55 
2. Arm· Swinging .39 
12. 3P .33 
10. 2P .29 
This factor of tapping rate or small muscle movement is not so clearly 
defined as in all the previous cases observed, but the interpretation is 
still dearly indicated. For sOille reason, the tappings of the 1\-10 smaller 
size patterns with the preferred hand do not exhibit as much saturation in 
this factor as in all the other cases. But physostigmine is supposed to 
cause Ii! contraction of skeleta1 muscle and overdoses cause muscular weak-
ness. If the effect was a minor one that could be overcome with effort, it 
is likely that automatic or customary actions would be affected most, since 
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they would usually be performed without effort. Such tasks would be the 
smaller size patterns with the preferred hand. Also the arm swinging task 
present is a more customary task than the other large muscle movement tasks, 
so that it would likely fit this interpretation. Its presence in the small 
muscle movement factor may be due to the lack of shoulder and trunk muscle 
involvement in that subjects weTe observed to swing the arm from the elbow 
rather than from the shoulder. Such a change in the task may have resulted 
fram the contraction of the skeletal muscles caused by physostigmine. Oddly 
enough the presence of Arm Swinging was also observed in this factor in the 
atropine condition. 
Factor B 
Tests 
3. Arms Parallel 
4. Arms Symmetrical 
2. Arm Swinging 
7. Time Reproduction 
Loadings 
.84 
.65 
.52 
.36 
This large muscle movement factor with the inclusion of the time experi-
ence implication was observed in identical form in the normal condition 
where the interpretation was explained. Physostigmine apparently had no 
effect on 1ts factorial composition. 
Factor C 
Tests 
5. Circles 
6. Lines 
Loadings 
.70 
.67 
This drawing speed doublet has been maintained intact throughout all 
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the conditions. It is interesting that no test of subjective time accom-
panles this doublet as it has in every other condition. This may mean that 
th~re is some change brought about in subjective estimates of time by phy-
sostigmine. On the other hand it is equally possible that drawing speed 
was altered by physostigmine, perhaps because of the contraction of skele-
tal muscle, so that it no longer tends to be related to a subjective esti-
mate of time. 
Faetor D 
Tests Loadipgs 
17. 2BPN .69 
19. 3BPN .65 
15. 4BP .62 
21. 4BPN .61 
13. 3BP .47 
11. 2BP .41 
This ~s elearly the silence interval factor which has been observed in 
previous conditions. It seems resistant to change that may be produced by 
the administration of physostigmine. Recalling the interpretation regard-
ing the effects of physostigmine on customary motions given with Factor At 
there may be some hint of a similar occurrence in the somewhat lower load-
ings of measures 13 and 11 in Factor D. The measures are the corresponding 
silence intervals for the patterns discussed in Factor A of this condition. 
Factor E 
Tests 
9. Metronome 
7. Time Reproduction 
8. Time Production 
Loadings 
.51 
.52 
.39 
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This is the factor of subjective time. It was exactly duplicated only 
in the atropine condition previously. In Factor C of this condition there 
was some question as to whether the tests of drawing or the teets of sub-
jective time had been altered by physostigmine. Since these tests do not 
define a single factor in either the normal or placebo condition, the evi-
dence seems to indicate that the tests of subjective time have undergone 
alteration such that they now serve to define a single factor. 
Pactor F 
Factor P seems best described as the specific factor for reading rate. 
In general, physostigmine does not seem to have produced much ovaall 
change in the domain of tempo. The basic factors~ill seem to retain their 
basic identification. A few minor changes were suggested as resulting&om 
physostigmine but these did not alter the structure to an appreciable degree. 
The tests most affected seem to be the measures of SUbjective ti~. If 
the stress of the experimental situation was present, the effects of phy-
sostigmine may have to a certa~n extent, been counteracted. This observa-
tion is made with the assumption that sympathetic dominance and the effects 
of a parasympathetic stimulant are antagonistic. 
This completes the condition by condition analysis of the various fac-
tor structures. The following will involve the crucial comparisons of the 
various conditions of the research. The comparisons will be performed by 
relating each factor of one condition with all the factors from the other 
condition by means of the coefficient of congruence. The indices are not 
correlation coefficients but have the same range and are interpreted simi-
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larly. According to Harman (1960) there does not seem to be a significance 
interpretation for these indices. In the literature, Harman says that 
Tucker has interpreted a coefficient of .45 as definitely low and therefore 
not indicating congruent factors. 
The first comparison will be between the normal and placebo conditions. 
While these measures are helpful in making available a quantitative measure 
of the relationship of two factors. it obviously can only give a general 
picture and detailed analysis can only be done by inspection. Table 1 pre-
sents these coefficients for the normal and placebo condition comparison. 
Throughout the comparisons that follow the factors designated by letters 
shall also be identified by code words as to the interpretation made for 
each. The code words refer to the corresponding interpretations of each 
factor in this manner. 
Sil - silence interval factor 
Draw - drawing speed factor 
Small - small muscle movement factor or tapping speed factor 
Large - Large muscle movement factor 
TLae - subjective time factor 
Read - reading factor 
Met - metronome factor (preferred rate) 
Res - residual factor 
($) - specific factor 
Normal 
CODdition 
Table 1 
Coefficients of Congruence in the Comparison 
of the Placebo and Normal Condition 
Placebo Condition 
Pactors and Code 
Factors Code A 
Large 
B 
Small 
C 
Draw 
D 
Sil 
A Su 
.043 .021 .098 .983 
B Draw 
.040 .154 .855 :tm! 
C Small -.005 .982 :tmr .011 
D Large .944 -:074 .140 .015 
E Time .035 .112 .238 -.126 
P Read (8) -.102 -.275 -.239 -.054 
E 
Read 
-.174 
.286 
.166 
.099 
-.161 
.408 
-
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F 
Time 
.101 
.ns 
.122 
-.037 
.707 
-
-.065 
The factors exhibiting the highest degree of similarity from the nor-
mal to the placebo conditions are the silence interval, small muscle move-
ment, large muscle movement and drawing speed factors in that order. An 
appreciable degree of similarity is also observed in the subjective time 
factor in theae conditions. The P Pactor of the noraal condition and the 
E Factor ot the placebo condition have an indication of similarity because 
both are, for practical purposes, specifics of rate of reading. On the 
whole the similarity between the two conditions is very good, indicating 
very little effect due to the administration of the placebo. This study 
of placebo effects by way of the strueture of the tests employed is 80me-
what novel. Tke question may be raised as to how much placebo effects 
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would be found in other situations when studied from the factorial view-
point. 
Next, the normal condition will be compared with the atropine condi-
tion to assess the change, if any, due to atropine in the light of the nor-
mal condition. This is presented in Table 2. 
Normal 
Condition 
Table 2 
Coefficients of Congruence in the Comparison 
of the Atropine and Normal Conditions 
Atropine Condition 
Pactors and Code 
Factors Code A 
Small 
B 
Draw 
C 
Large 
D 
Time 
A S11 
.081 .005 -.033 -.092 
B Draw 
.140 .850 .071 .270 
C Small .870 -'7O'7t1 -.011 .155 
D Large 112 .006 .956 .114 , 
-E Time .218 -.002 .031 .530 
P Read (8)-.475 -.003 .032 -:om5 
E 
S11 
.916 
-:n7 
.256 
.002 
-.015 
.048 
F 
Res 
.006 
.080 
.088 
-.080 
-.176 
.011 
An inspection of Table 2 indicates that the factors exhibiting the 
highest degree of similarity are, in order, the large muscle movement fac-
tor, the silence interval factor, the small muscle movement factor, and 
the drawing speed factor. Their high coefficients reflect little change 
due to atropine. There was a lowering in the similarity of the time 
factors for the two conditions. This seems to indicate an effect of 
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atropine on the measures of subjective time. Further, the Reading specific 
of the normal condition is, in the atropine condition, found in the small 
muscle movement factor, accounting for the similarity found between Factor 
F of the normal condition and Factor A of the atropine condition. 
In sum, atropine's effect on the domain of tempo seems to have been 
mainly in the measures of subjective time and the reading task. 
The ,next condition ;(.0 be com.pared with the normal is too dexedrine. 
On the basis of its pha~colo,ical characteristics, it would be expected 
to affect the domain in a fashion similar to atropine. This comparison is 
found in Table 3. 
Nonnal 
Condition 
Factors 
A 
B 
C 
D 
E 
F 
Table 3 
Coefficients of Congruence in the Comparison 
of the Dexedrine and Normal Condition. 
Dexedrine Condition 
Factors and Code 
Cpde A B C D 
Sil &: Large Draw Res 
Small 
Sil .146 .022 .057 .467 
Draw .228 .019 .787 -.237 
Small .735 .072 .029 -.046 
Large .010 .914 -.061 -.012 
Time .036 -:or! .188 .029 
Read. (8) -.131 -.022 -.089 .365 
E F 
Read 
" 
Time 
Time 
-.089 -.035 
.031 .361 
-.012 .341 
.085 .307 
.324 .395 
.582 -.364 
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Table 3 is conspicuous because of the lack of very high values which 
were present in the previous tables. This indicates lower agreement bet-
ween comparable factors and at the same time suggests that the effects of 
dexedrine in altering structure are quite pronounced. The large muscle move-
ment factor retains its identity, as does the drawing speed factor. The 
unique definition of the silence and the small muscle movement factors in 
the normal condition are both in appreciable agreement with Factor A of the 
dexedrine condition, indicating that the two factors have been combined in 
the latter condit inn. There is hardly any agreement in the factorial defi-
nition of time from one condition to the other. Reading shows fair agree-
ment. In general, only the large muscle movement factor remains unaffected 
by dexedrine. The drawing speed composite retains much of its original iden-
tity, but the others undergo more of a radical revision. It was suggested 
that the subject may have entered the testing with a sympathetic dominance. 
If so, this would be heightened by dexedrine. 
Dexedrine thus seems to have more of a disruptive effect than atropine. 
Both were administered in dosages considered to be the usual therapeutic 
treatment. The therapeutic purposes of each are different, however. Dexe-
drine is usually given as a stimulant in depressed cases, but atropine is 
mostly utilized in pre-operatave care. On these bases it is difficult to 
say which has the greater psychological effect in terms of normal thera-
peutic dose. The evidence presented here seems to indicate dexedrine. 
The comparison of the chlorpromazine and normal conditions is presented 
in Table 4. 
Normal 
Condition 
Table 4 
Coefficients of Congruence in the Comparison 
of the Chlorpromazine and Normal Conditions 
Chlorpromazine Condition 
Factors and Code 
Factors Code A 
Sil 
B 
Small 
C 
Large 
D 
Draw 
E 
Met (8) 
A Sil .947 -.050 -.031 -.004 .013 
B Draw -:orr .091 .136 .120 -.204 
C Small .115 .972 -.042 -:Os'i .052 
D Large -.011 -:oi2' .963 .051 .015 
E Time -.107 .209 -:on .451 .693 
11' Read (8) -.089 -.195 -.204 -.193 -:on 
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11' 
Read " 
Time 
-.022 
.246 
.034 
.126 
-.313 
.481 
Large muscle movement, small muscle movement, and silence interval factors 
are practically identical in the two conditions with very high coefficients 
of congruence. Drawing and time estimation factors show appreciable a1mi-
larity, the latter mainly because bhe test Metronome has a high loading in 
Factor E of the normal condition. In other words the only appreciable ef-
fects of chlorpromazine are in the realm of subjective experience of time 
and rate of reading. The counterbalancing effects of chlorpromazine on a 
possible sympathetic dominance was offered as the explanation. 
The final condition to be compared with the normal is the physostig-
mine condition which is presented in Table 5. 
Normal 
Condition 
Factors 
A 
B 
C 
D 
I 
11' 
Table 5 
Coefficients of Congruence in the Comparison 
of the Physostigmine and Normal Conditions 
Physostigmine Condition 
Factors and Code 
Code A B C D E 
Sm' 11 Large Draw Si1 Time 
Sil .163 -.010 .051 .904 -.026 
-Draw .173 .142 .677 .121 .413 
-Small .876 -.058 -.040 .224 .267 
Large -:m .947 -.058 .074 .247 
Time .U6 -.147 .383 -.004 .341 
Read (8) -.242 -.007 -.028 .017 -.143 
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F 
Read 
(8) 
-.098 
.198 
.031 
-.193 
-.315 
.395 
The factors of large muscle movement, silence intervals, and small muscle 
movement are in high agreement in the normal and physostigmine conditions. 
The drawing composite shows appreciable similarity in both conditions. The 
time and specific reading factors of the normal condition show no appreci~ 
able conformity in the factors of the physostigmine condition. The effect 
of physostigmine seems to be limited to experience of time and reading. 
Much bhe same thing was seen in the case of chlorpromazine. 
The final two comparisons will be between the drugs which, according 
to their pharmacological characteristics. are likely to have similar effects. 
Table 6 presents the comparison of the atropine and dexedrine condi-
tions. 
Atropine 
Condition 
Factors 
Table 6 
Coefficients of Congruence in the Comparison 
of the Dexedrine and Atropine Conditions 
Dexedrine Condition 
Pactors and Code 
Code A B C D 
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E II 
Small &: Large Draw Res Read &: Time 
Sil Time 
A Small .681 .054 .002 -.668 -.225 .386 
B Draw 7ffi' -.033 .717 -.050 .042 -.009 
C Large -.014 .954 .. :054 .042 .105 .169 
D Time -.168 .043 .157 -.104 .646 .623 
E Sil .822 -.047 .034 .330 7ii9 ~ 
-F Res .001 -.058 .320 -.240 -.384 -.085 
The large muscle movement and drawing composite factors are the only ones 
in the two conditions in which there is high and unambiguous agreement. 
The amall musc Ie movement and silence factors of the atropine condition 
both have appreciable agreement with Factor A of the dexedrine condition 
since it is a composite of the two. The presence of more than one appreci-
able value in any row or column, of course, means a change in structure 
from one condition to the other. Thus, while in the atropine condition 
where there was on,y one factor oe subjective time, it is split in the 
dexedrine condition. In general, then, these two drugs obviously have 
very limited effects which are similar. In fact where high agreement is 
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noted, it is more likely agreement due to the lack of effects of both drugs 
on the factoBs involved. rather than both drugs affecting bhese factors ift 
the same way. The conclusion on the basis of the evidence. then. must be 
that despite the fact that one is a sympathetic stimulant (dexedrine) and 
the other a parasympathetic depressant (atropine) the two drugs have very 
little in common with respect to the introduction of changes in the domain 
of tempo. 
The final comparison to be considered is that of the chlorpromazine 
and physostigmine conditions. These results are found in Table 7. 
Table 1 
Coefficients of Congruence in the Comparison 
of the Chlorpromazine and Physostigmine Conditions 
Physostigmine 
Condition 
PaAtors Code 
A Small 
B Large 
C Draw 
D S11 
E Time 
A 
S11 
.234 
.010 
-.088 
.885 
-:068 
P Read (s) -.091 
B 
Small 
.873 
-7m 
-.056 
.135 
.322 
.003 
Chlorpromazine Condition 
Pactors and Code 
C 
Large 
.059 
.919 
... -:1)'1i1 
-.014 
.291 
-.244 
D 
Draw 
-.058 
.083 
.860 
':oi1 
.289 
.... 159 
E 
Met (8) 
-.054 
.... 048 
-.038 
.061 
.327 
-.454 
po 
Read &: 
Time 
.011 
.321 
-.057 
-.OS4 
.138 
.416 
Both chlorpromazine and physostigmine were in agreement with the normal 
condition in the four situations underscored in Table 7. However, the value 
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in the drawing speed compoeite for physostigmine was not in as high agree-
ment with the no~l as it is in this case with chlorpromazine. This seems 
to indicate that this composite may have been affected by both and that the 
direction was similar for each. No similarities again are seen in the fac-
tors of subjective time or reading worthy of comment. In summary, the con-
elusion seems to be that both physostigmine and chlorpromazine had little 
effect on the domain of tempo and that, therefore, what shows up as a high 
degree of similarity between the effects of the two drugs is in actuality 
their mutual identity with the normal condition. 
Discussion 
This section will be quite brief since a great part of what would 
ordinarily appear here t was more properly treated with the interpretation 
of the factor structures and the analysis of the comparisons. 
In discussing the relationship between the normal and placebo condi-
tions it was noted that they were very similar in structure. This not 
only serves to indicate that the effects on the domain of the tempo tasks 
under observation were minimal, but allo suggests in a ~ ~ propter 
hoc fashion that the counterbalancing effects of the design were successful. 
-
Obviously if differences had been observed between the structures, the de-
sign would have to have been assumed successful and the effects attributed 
to the placebo. However t s,ince there werE: no differences of major import, 
the conclnsion must either be that the placebo hac no effect and that the 
counterbalancing of the design was successful, or that there were effects of 
the placebo and tha.t these were eJltactly offset by the effects of poor coun-
terbalancing in the design. The latter interpretation &eems much less 
plausible because of its high improbability. 
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Some critics may object that the various doses employed in the re-
~~Ar~h were not determined by <.1lC&IlS of so many milligrams per kilogram of 
body weight. One obvious reason was the ia;.practicality of the notion in 
terms of personnel. Anvther person who could not be used in the testing 
becsuse of the double-blind control would have to b<c. available to prepare 
the various doses of drugs. Besides its impracticality, the technique was 
not advised by the experts. Further, common medical usage of these drugs 
does not ordinarily employ th:f.s technique. It seems to be restricted to use 
with very ~mall children, critical patients and critical situations. All 
the drugs have what is known as the normal adult therapeutic dose and it 
was decided that this satisfied the demands of this research. 
Of the factors employed in this research, those involving drawing and 
large muscle movement seem quite resistant to any change due to the drugs 
employed. Small muscle movement and silence interval factors seem to have 
been affected only in the dexedrine condition in so far as their identifi-
cation is concerned. The structure has become Bomewhat more oblique in 
the case of atropine. The result with dexedrine seems at the outset to be 
somewhat at variance with the findings of Cabanski (1961) and Condon (1965). 
Both reported negative findings. Their findings were based on conventional 
tests of si.gnificance VYhereas those of the present study were based on the 
factorial approach. This situation is in agree~,nt with the arguments pre-
sented previously in connection with Eysenckts opinion concerning his re-
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commended approach to the study of drug effects. That 1s. the conflicting 
results indicae that factorial composition can change despite the lack of 
significant differences. Further, the evidence suggests then. that dexedrine 
need not syatemat ically affect all the compomout tests of a given factor. In 
terms of drug research in general. it seems appropriane to exercise extreme 
caution in forming conclusions based on tests of significance without the 
aid of a dimensional analysis. At any ra.tt:: the use of the factor analytic 
technique seems to offer a great deal in the study of d~g effects. 
Since the areas most responsive to the influence of the various drugs 
were those of subjective time and reading. perhaps fu~ure research may want 
to develop more teats in these areas so as to have a better means of delinea-
ting the changes that may occur here. In the present research the subjective 
time factor was a quite complex one. but it was definitely sensitive to the 
various treatments. The literature does report the reliabilities of these 
tests to be the lowest of those employed in this study and, therefore, it 
may be suggested that this accounts for the caange in factorial composition 
of these tests in the drug condition. However, this seems contra-indicated 
by the stmilarity of the factorial composition, even in these areas. in the 
normal and placebo eondition. 
Further, it may be observed that the most resistant factors were those 
which were more physiologically grounded. Those of a more complex psycho-
logical nature seemed less resistant and more sensitive to reflect the in-
fluence of the various agents at the specified dosage levels. Therefore, 
depending on one's purpose he may select variables of tempo along this 
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physiological-psychological continuum to fit the purposes of his research. 
As was noted in the analysis of the structures and their comparisons, 
a factor of subjective time defined by measures of time production and pre-
ferred metronome rate was observed in the same form in both the normal and 
placebo conditions, but not in any of the drug conditions. In the physos-
tigmine and atropine conditions the measure of time reproduction was added 
to the two above to define the factor. In the other two drug conditions 
the similarities were even smaller since Time Production and Metronome do 
not combine to define or help define any given factor. This is ext~ly 
interesting considering the controversy between a psychological and phy-
siological basis for time estimation. The evidence presented here seems 
to indicate that neither alone can offer a satisfactory MXplanation. How-
ever, the supporters of a physiological basis seem to have the weight of 
the evidence on their side, since the changes in the factorial identifica-
tion of the pertinent measures are much smaller in the two psychologically 
different conditions (normal and placebo) than in the physiologically dif-
ferent conditions. Yet since there were changes in bothatuations but riot 
of the same magnitude, it seems to be a reasonable opinion that there is a 
physiologieal basis for time estimation that is modified in some instances 
by psychological experiences. A statement such as this seems to fit the 
evidence present in this research. Haley's (1963) conclusions provide ad-
ditional evidence for this opinion. He found estimates of time appearing 
in factors defined by measures of physiological functions. 
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In general, the evidence of this research 4efinitely supports a plura-
listic interpretation of the domain of tempo. Also since the factors des-
cribed by Rimoldi were all recovered in this Ie search. further verification 
is given to his conclusions regarding personal tempo. 
At this point it may be beneficial to remind the read2r that all find-
ings and conclusions must be restricted to the pharmacological agents and 
dosages employed. From the evidence sllbmitted it does not seem possible 
to generalize from one drug to others of a similar classification. That 
is, not all stimulants can be expected to yield similar results, And to 
go a step further one cannot expect to find similar effects on the domain 
of personal tempo from sympathetic stimulants and parasympathetic depres-
sants. The same thing can be said for the relationship between sympathetic 
depressants and parasympathetic stimulants, though here the evidence is less 
convincing. No evidence can be supplied concerning various agents all fit-
ting under the classification of 'sympathetic stimulants. for example. This 
could ~ery well be an area for future exploration. At any rate each drug 
appears to be worthy of study in its own right. depending, of course, on 
ita importance to the field. 
Another point of caution is the sample employed. It was basically 
composed of parsons of a high educational level. Since there is definite.ly 
a relationship between the psychological and physiological, it would be 
quite presumptuous to generalize these findings beyond the population of 
this research. 
If the author may be permitted a casual observation, it seems that the 
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the _vel of conscious attention inherent in a given task, may be an impor-
tant variable to consider in evaluating the drug effects on that task. 
For example, the Arm Swinging task is one to which very little conscious 
attention would be expected to be paid. That is, one could reasonably 
assume that, since it is one which a person performs every day, it would 
be performed in the testing session on a more automatic level. If this is 
so, it seems reasonable that the subject would expend less conscious effort 
in trying to overcome the effects of a given drug on such a task, if he 
were aware of them. In other words, tasks performed at a more automatic 
level would seem to be more sensitive to drugs effects than those to which 
attention would be directed to insure their proper execution. A suggestion 
such as this may explain why the Arm Swinging task appears also in factors 
other than the lar~e muscle movement factor in the drug condition, whereas 
the Arms Parallel and Arms Symmetrical tasks exhibit no such tendencies. 
I 
This seems to be quite provocative for future research. 
If tempo is a fundamental aspect of the total personality, then one 
would not expect dramatic changes in the domain of tempo under drug dosages 
which did not elicit similar changes in the total personality. The experi-
menter, though certainly no expert in the 8.rea, wall not able to detect in 
his observation such changes in the personality of the subjects. Indeed, 
such changes would not be expected from the dosage levels of the various 
drugs employed. Thus with no marked changes in the total personality, one 
should not expect to find them in the domain of personal tempo. Such, in-
deed, was the finding £>apecially in those factors which had been determined 
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by the literature to be quite stable. These, the present author charac-
terized as being more toward the physiological pole of a psychological-
physiological continuum. This observation of the relationship between tem-
po and the total personality, while suggested by other authors, certainly 
needs systematic empirical investigation. The purpose here was merely to 
indicate that such an investigation was not unwarranted. 
Pinally, then, it is necessary to integrate the various points dis-
cussed in this section. to see how they fit into a meaningful whole. A 
psychological-physiological continuum for the tempo variables was sugges-
ted. Psychological and physiological effects of the pharmacological agents 
must be admitted realizing that the two interact very closely. Conscious 
attention to task and an organism under~e predominant influence of the 
sympathetic nervous system, as a psychological effect of the. experimental 
situatiol\ were suggested as inflUt~ncing the results. In general the results 
indicated p4Sctically no change in structure between normal and placebo 
condit ions, little between normal and those conditions equivalently depres-
sing the sympathetic nervous system, and the greatest between the normal 
and those equivalently stimulating the sympathetic nervous system. The 
lack of difference between the normal and placebo conditions was interpreted 
to mean that the psychological effects of the experimental situation were 
not sufficiently strong in th~mselv~s to bring about a change in structure. 
The suggestion that there may have been some, thou.gh ra.ther weak, psycho-
logical effects of the placebo condition SMllt'!' to agrel? with the. bel<. of 
ehange b~tween the normal and those conditions eqllivalantly d~pressing the 
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sympathetic nervous system. That is, it is assumed that the effects of the 
placebc condition would be tno8~ similar to any stressful situation or that 
a syru.pathf.;tic: dominance would describe the organism in this si.tuation. 
Agt:ots equivalently de.pressing the action of the sympathetic nervous system 
would tend to counteract such a sympathetic dominance j the end re.sult of 
s~h an interaction would be a dampening not only of tae placebo effects, 
but a1.0 of the agents invol 'ted. This interpretation seems eonaistent with 
observed results. nlC interyretation of the appreciable changes from the 
normal to those conditions equivalently stimulating the sympathetic nervous 
system seems also consistent with the suggestion of 8)"Ulpathetic dominance. 
That is, instead of a counterbalancing effect due to the interaction between 
placebo e:ffeets and agent effects, there is a summation effect in which the 
sympathet ic dominance. is €nlbanceCi. This then, wou Id exp 1 ain the rather pro-
nounced change in structure., especially noted in the de'lCedrine condition. 
At a mere specific level, it was observed that tests tow8£d the physiological 
end of the above mentioned continuum were more rf:sistant to change than 
those located toward the Vsychological end. It seems characteristic of the 
phydologically designated tasks that more conseious attention would be paid 
their proper execu·tion. This would seem to allow fot" less departure froll! 
what the subjects would consider normal erecution. The psychologically de-
signated tasks seetD to be more automatic or habituated, thus reducing con-
scious attention and allowing a greater departure from the normal be.cause 
of experimentally introduced influences. One cannot discount entirely the 
possibility that the tasks of a more complex psychological nature are less 
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resistant to change because they are the result of the modification of a 
basic physiological process by learning and that the learned aspects are 
more susceptible to disruption than the underlying physiological process. 
Therefore, the fewer the learned aspects of a task there are, the smaller 
the susceptibility to change. 
It tempo measures are to be considered as possible measures of per-
sonality, then the more stable aspects of tempo should be investigated as 
useful correlates. If the stable physiological measures may be regarded 
as measures of personality, it may be concluded that, since the pertinent 
tempo measures underwent little or no influence because of the effects of 
the various agents employed, personality would undergo little or no change. 
The relationship between the stable tempo measures and personality remains 
to be empirically established, of course. 
Pinally, with respect to the tempo variables themselves and correspond-
mg drug influences, no systematic changes may be described as delineated 
in a previous paragraph. However, here again the evidence strongly suggests 
that tasks more physiologically grounded are quite resistant to change. 
The evidence is more convincing concerning agents stimulating the sympathetic 
nervous system than for those depressing the same. 
Summary 
The purpose of this research was an investigation of the permanence 
of a domain of personal tempo under the influeace of four pharmacological 
agents, viz. atropine sulfate, chlorpoomazine hydrochloride, physostigmine 
salicylate, and dextro-amphetamine sulfate. The domain studied was com-
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posed of factors from previous research (Rimoldi, 1951; Haley. 1963, 1965; 
Allport and Vernon, 1933) where they had been shown to be stable and re-
producible. These factors were large muscle movement, small muscle move-
~ntf drawing speed, and the silence interval. Tasks of time estimation 
were included because of their compelling interest and obvious relevance to 
the area being studied. 
In order to study the uncontaminated effects of the various agents 
and have a basis of comparison, six experimental conditions were employed: 
normal (no agent adminis~.red)f placebo, atropine. dexedrine, chlorpromazine. 
and physostigmine. The design called for a counterbalanced presentation of 
the six conditions such that each condition appeared approximately the same 
number of times in each of the six possible orders. 
The data was then collected by condition and the in~ercorrelations 
computed for the twenty-one measures employed to reflect performance on the 
fifteen tempo tasks. A factor analysia was performed for each of the six 
conditions using the prinCipal axes method. Oblique graphical rotations 
were then taken by hand on each factor solution until the best approxima-
tion to simple structure was Obtained. The final rotated solutions for 
each condition were then anal}zed by inspection and compared according to 
the coefficients of congruence. Interpretations were suggested. The 
general findings were: 
1) The structure of the normal condition proved to be as ~xpected on 
the basis of the literature, indicating that the factors employed were veri-
fiable and reproducible and that a legitimate basis of comparison existed. 
13 
2) The structures of the normal and placebo conditions were practi-
cally identical, indicating that placebo effects were minimal, and because 
of this that the design was successful. This latter observation obtains 
increased support from the first finding. 
3) The structures of the chlorpromazine and physostigmine conditions 
were quite similar to the normal condition indicating only minor influence 
on the domain of tempo due to the administration of these agents. Since 
both agents are antagonistic to sympathetic dominance and since such domi-
nance may be present because of the stress of the testing situation, it was 
suggested that the effects of these two agents were reduced by this anta-
gonism. 
4) The structures exhibiting the most change were those of the dexe-
drine and atropine conditions. Supposing a sympathetic dominance, the ef-
fects of these two agents would tend to be heightened. Of these two con-
ditions, the dexedrine condition showed the greatest deviation from the 
structure of the normal condition. It was proposed that a therapeutic dose 
of dexedrine may be more "powerful" in terms of psychologieal effects than 
such a dose of atropine. 
5) '!be basic faetors selected to represent the domain of tempo showed 
the greatest resistance to the influence of the agents involved. It was 
proposed that these factors .re defined by tasks which may be characterized 
as being more toward the physiological pole of a physiological-psychological 
continuWll. 
6) Tasks of time estimation and allied measures showed the greatest 
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sensitivity to the influence of the various agents. These seemingly can 
be characterized as being more toward the psychological end of the above 
mentioned continuum. 
7) In the light of the findings in 5 and 6 the evidence of this re-
search points to the importance in tempo drug research. of analy~ing the 
tasks involved in terms of a physiological-psychological continuum. 
8) Pinally, no dramatie changes in the domain of tempo, as defined 
in this research, can be said to have occurred. This evidence seems to 
be in agreement with the concept of tempo as a basic aspect of the total 
personality. That is, since no dramatic changes as a result of drug in-
fluence were observed in the total personality as reflected in tb~ obser-
vation of the experimenter, one would not expect to observe such changes 
in the domain of tempo studied. A subtle assumption is involved here and 
it is that the tasks defining the factors in the domain of tempo be chara-
cteristically at the physiological end of the physiological-psycholQgical 
4ontinuum. The reason for this is that tests tending toward the psycho-
logical end have been seen in this research to undergo change despite the 
lack of dramatic changes in the total personality. Though the evidence 
from this research bearing on this problem is limited fram the standpoint 
of personality aeasures, it seems sufficient to indicate that if personal 
tempo is to be regarded as a fundamental aspect of personality, its chara-
cteristic measures should be those wbich tap functions as close to tbe purely 
pbysiological as possible. At any rate it is felt that this contention de-
serves serious consideration for future investigation. 
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Table 8 
tntercorre1ation between Variables 
for Nonal Condition 
Variable 
Vari-
able 
1 2 3 It. 5 6 7 8 9 10 11 12 
1 
2 -13 
3 -10 64 
4 00 62 89 
5 -06 37 04 18 
6 -06 41 -03 20 69 
7 -10 42 40 48 51 46 
8 lit. 06 09 26 11 34 -05 
9 -38 39 09 22 38 3' 09 51 
10 00 -14 -25 -19 31 08 25 -32 -09 
11 -08 -24 -36 -25 20 -04 12 -52 -28 66 
12 10 -16 -28 -19 16 -02 05 -22 -08 9S S5 
13 -15 -29 -42 -31 08 -17 -10 -46 -17 58 95 53 
14 12 -19 -34 -27 06 -07 04 -33 -15 91 55 96 
15 -36 -22 -36 -25 06 -10 -17 -41 07 46 80 40 
16 -15 -11 -29 -27 12 00 01 -38 -04 92 55 94 
11 -21 -22 -)0 -23 04 -11 05 -56 -28 65 92 56 
18 -01 -15 -26 -21 03 -07 03 -39 -13 88 S3 93 
19 -20 -18 -35 -23 -03 -16 -10 -52 -14 53 88 50 
20 08 -17 -28 -25 -03 -14 -03 -41 -19 86 51 93 
21 -36 -24 -36 -25 -06 -13 -15 -43 01 46 78 41 
Note.-Dectmal places have been omitted. 
(Table continued on next page) 
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Table • 
latcrcorrelat1ena between Variable. 
:or lRonial Coac:l1tlQWi 
I 
• I b li j r I I 
Variable-
Vari-
able I b 
13 tIl t' 16 17 1. 19 20 21 
• 1 
1 
2 
3 
4 
5 
6 
1 
a 
9 
10 
U 
12 
1J 
1_ 52 
15 8' 40 I' SIa ,." so 17 at s. 80 63 
11 52 96 ., 
" 
.1 l' .3 53 92 56 91 58 20 51 97 41 M-
" " 
56 
21 .S 43 tit '2 U S2 9S 46 
I n If._ .-tlecl~l ptftC4. ha1f6 'beitJ\ _itt .. ". 
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Table 9 
Intercorrelationa between Variablea 
for Placebo Condition 
Variable 
Vari-
able 
1 2 3 Z. 5 , 7 8 9 10 11 12 
1 
2 53 
3 20 56 
4 -06 51 78 
5 00 15 -15 14 
6 -26 20 -10 25 75 
7 14 4S 07 27 73 64 
8 01 17 17 44 27 25 26 
9 20 25 12 39 53 40 43 45 
10 -16 -10 -26 -45 -06 -14 -21 -36 24 
11 01 -18 -25 -47 -24 ... 36 -34 -63 -12 67 
12 -06 10 -04 -25 -10 -11 -01 -36 18 87 '2 
13 00 -14 -2S -45 ,:-16 -27 -20 -69 -09 64 90 68 
14 -011 14 00 -22 -16 -20 -08 -33 12 82 56 98 
15 -08 -20 -36 -47 -13 -31 -24 -57 -09 57 86 58 
16 -13 -05 -20 -40 -02 -05 -11 -42 18 93 61 94 
11 00 -31 -30 -53 -15 .. 24 -33 -68 -13 63 88 58 
18 -05 00 -OS -29 -09 -IS -10 -46 14 86 65 98 
19 -09 -23 ... 29 -47 -ll -26 -22 -71 -13 61 88 58 
20 -07 OS -07 -31 -06 -11 -08 -45 16 90 62 97 
21 -08 -27 
-3' -46 -08 -27 -24 -62 -10 SS 83 52 
Note.-Deei:mal places have been omitted. 
(Table cObtinued on next Pale) 
81 
Table 9 
Intercorrelatlona between Variables 
for Placebo Condition 
Variable 
Vari-
able 
1 2 3 
-
5 , 7 8 9 10 11 12 
1 
2 
3 
-5 
6 
7 
8 
9 
10 
11 
12 
13 1_ 
62 
15 94 54 
16 68 92 60 
17 95 SO 89 64 
18 74 96 6' 96 65 
19 96 53 ~3 63 93 68 
20 70 95 61 98 63 98 64 
21 94 48 98 57 91 62 96 57 
Note.-Decimal places have been omitted. 
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Table 10 
Intercorrelationa between Variables 
for Atropine Condition 
Variable 
Vari-
able 
1 2 3 4 5 , 7 8 9 10 11 12 
1 
2 -08 
3 21 57 
4 2' 43 90 
5 07 22 -14 III 
I -06 07 -06 18 82 
7 10 25 10 13 35 31 
8 0' 31 14 14 22 06 61 
9 -02 14 14 19 08 00 30 51 
10 -51 47 02 -02 25 22 -08 02 24 
11 -35 13 -03 -0, 06 04 -05 -24 03 72 
12 -62 31 -09 -20 -06 -07 -01 09 20 88 76 
13 -45 02 -13 -20 -19 -24 -01 -11 04 59 89 82 
14 -55 28 -10 .. 20 -03 -08 13 21 27 80 72 97 
15 -35 -07 -19 -25 -27 -38 00 02 -08 35 66 68 
16 -63 33 -14 .. 23 01 ... 02 02 12 18 90 74 98 
17 -44 06 -17 -24 -15 -18 -13 -26 -69 63 91 77 
18 -62 32 -10 -19 01 01 Olf. IS 14 85 69 98 
19 -45 05 -17 -25 -24 -26 -05 -18 -06 54 81 80 
20 -56 28 -08 .. 16 ... 09 -09 OS 08 13 77 68 94 
21 
-3' -12 -20 -22 -35 -43 -19 -13 ... 23 28 54 58 
Note. -Decimal places have been omitted. 
(Table continued on next page) 
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Table 10 
Intercorrelations between Variables 
for Atropine Condition 
Variable 
Vari-
able 
13 14 15 16 17 18 19 20 21 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 81: 
15 90 70 
16 76 94 62 
17 92 72 77 78 
18 76 96 65 97 74 
19 94 17 88 76 94 78 
20 78 93 68 93 77 97 84 
21 78 56 89 56 77 61 87 69 
Note.-Decimal places have been omitted. 
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Table 11 
Intercorrelationa between Variables 
for Dexedrine Condition 
Variable 
Vari-
able 
1 2 3 4 5 6 7 8 9 10 11 12 
1 
2 -19 
3 07 45 
'+ -03 50 80 
5 20 -26 -12 05 
6 18 -35 01 11 79 
7 13 17 13 19 -04 08 
8 46 14 06 39 06 15 30 
9 12 26 10 33 46 29 04 37 
10 -15 01 -19 -18 06 11 27 -14 -14 
11 03 -13 -08 .. 25 -05 00 IS -23 -46 81 
12 -07 14 -13 -06 -12 -09 33 -05 -19 92 78 
13 04 01 -08 -16 -14 -16 11 .. 17 -44 74 92 84 
14 -03 13 -09 -12 -21 -16 40 -04 -30 84 82 94 
15 04 OS -01 -08 -11 -27 04 -18 -33 59 78 72 
16 -14 01 -27 -27 -20 -IS 36 -09 -36 88 87 92 
11 06 -15 -16 -32 -16 -16 11 ... 24 -53 72 95 75 
18 -04 09 -13 -18 -32 ,-~O 33 -OS -41 7S 82 87 
19 04 04 -05 -23 -27 -28 19 -22 -53 60 85 72 
20 -01 04 -13 -21 -33 -31 37 -11 -47 74 84 87 
21 -01 17 -01 -16 -27 -39 07 -25 -41 54 77 64 
Note.-Decima1 places have been omitted. 
• (Table continued on next pale) 
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Table 11 
Intereorrelations between Variables 
for Dexedrine Condition 
Variable 
Vari-
able 
13 14 15 16 17 18 19 20 21 
1 
2 
3 
4 
5 
6 
., 
8 
9 
10 
11 
12 
13 
14 88 
15 90 69 
16 87 95 72 
17 95 81 88 86 
18 90 92 82 94 87 
19 93 81 89 82 94 93 
20 90 93 81 94 88 99 92 
21 .7 68 93 72 88 82 93 81 
Note.-Deeimal places have been omitted. 
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Table 12 
Intercorrelations between Variables 
for Chlorpromazine Condition 
Variable 
Vari-
able 
1 2 3 4 5 6 7 8 9 10 11 12 
1 
2 -07 
3 19 47 
4 01 60 88 
5 02 20 13 29 
6 19 08 02 13 84 
7 56 48 42 41 31 40 
8 07 16 16 27 28 32 02 
9 -24 28 19 38 63 46 29 21 
10 -11 07 -36 -45 -35 -35 14 -40 -10 
11 -19 -10 -45 -57 -56 -60 -24 -65 -38 65 
12 -04 01 -34 -36 -43 -45 ·13 -21 -04 81 56 
13 -24 -26 ·-53 ··62 -59 -63 -36 -58 -31 56 93 61 
14 22 -17 -42 
-"7 -SO -44 -12 -29 -21 70 55 91 15 -45 -27 -SO -48 -52 -60 -49 -42 -15 28 72 49 
16 -12 01 -40 -49 -41 -34 -18 -37 -24 90 68 86 
17 .. -24 -13 -52 -59 -SO -·52 -25 -61 -34 55 9S 51 
18 18 -03 -26 -38 -47 -37 -01 -27 -28 82 58 89 
19 -25 -24 -53 -60 -50 -57 -35 -61 -27 50 92 57 
20 21 -OS -29 -42 -48 -37 -OS -34 -32 80 60 85 
21 -48 -25 -48 -46 -49 -61 -58 -33 -13 28 71 49 
Note.-Decimal places have been omitted. 
(Table continued on next page) 
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Table 12 
Intereorrelations between Variables 
for Chlorpromazine Condition 
Variable 
Vari- 13 14 15 16 17 18 19 20 21 
able 
1 
2 
3 
4 
5 • 
6 
7 
8 
9 
10 
l1 
12 
13 
14 64 
15 87 48 
16 66 17 38 
17 94 52 78 63 
18 51 89 29 90 53 
19 98 60 88 60 93 50 
20 59 91 30 88 55 99 52 
21 81 46 94 40 74 28 86 28 
Note.-Dectmal places have been omitted. 
Vari-
Table 13 
lnte reorre 1 at ions between Variables 
for Phys08ticaine Condition 
Variable 
88 
able -----------------------------------------------------------
1 2 3 4 5 7 8 9 10 11 12 
1 
2 08 
3 10 41 
... 
-16 35 86 
5 16 -16 -05 21 
6 02 -03 -20 16 65 
7 -01 32 40 49 07 17 
8 05 -13 -15 03 17 31 36 
9 -04 02 19 37 30 44 52 36 
10 01 02 -36 -33 -10 13 20 22 23 
11 07 06 -25 -26 -10 18 25 24 19 94 
12 -07 10 
-1" -17 -28 -15 22 14 05 86 82 
13 -0,. 05 -19 -23 -18 -06 16 05 08 84 88 94 1" -08 23 -08 -05 -16 03 30 22 16 81 79 93 15 -06 -01 -12 -15 -10 -16 14 04 01 65 74 80 
16 -10 20 -12 -06 -14 14 28 26 18 84 84 87 
17 13 -02 -11 -23 -18 -08 04 -01 -12 72 83 77 
18 -20 25 -08 -03 -16 06 28 27 13 77 7" 8,. 
19 -02 -02 .05 -15 -16 -16 00 -04 -17 55 67 70 
20 -13 34 -06 -08 -30 -06 27 21 OS 77 74 88 
21 -10 -09 -20 -29 -19 -26 -15 -04 -26 54 62 69 
Note.-Dectmal places have been omitted. 
(Table continued on next pale) 
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Table 13 
Intereorrelations between Variables 
for Physostigmine Condition 
Variable 
Vari-
able 
13 14 15 16 17 18 19 20 21 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 88 
15 90 75 
16 84 97 11 
17 88 70 87 71 
18 78 95 67 91 62 
19 82 69 91 68 92 66 
20 79 95 64 93 63 96 63 
21 79 57 B8 54 87 54 93 S4 
Note.-Decima1 places have been omitted. 
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• Table 14 
Unrotated Principal Axes Pactor Solution 
for Normal Condition 
Pactor 
Variable 
1 II III IV V VI 
1 -10 -05 43 -05 -35 38 
2 -30 62 -28 -17 11 05 
3 -46 48 -20 -67 12 -06 
It -39 60 -29 -49 08 26 
5 04 64 -27 43 -26 -03 
6 -14 58 -20 52 -16 04 
7 -06 66 -21 -07 -34 -21 
8 -51 16 10 37 24 32 
9 -20 36 -25 'to 50 10 
10 84 42 23 06 -09 -13 
11 85 ... 04 -35 -01 -35 07 
12 82 35 40 03 07 11 
13 86 -18 -37 02 -10 14 
lit 84 27 43 -02 04 08 
15 78 -17 -51 08 22 04 
16 8' 31 28 02 20 -15 
17 88 
-0' -33 -13 -14 -04 18 86 28 33 -09 15 -02 
19 87 -16 -41 -09 04 20 
20 84 22 41 
-13 11 05 
21 80 -21 -41 00 22 04 
Note.-Decimal places have been omitted. 
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Tal>14 15 
llnrotat.a4 h Llloi.", 1 Axe. '""t(lll' bolut loa 
f_ Placebo ConditiCID 
hetor 
VariAble 
1 II III tv V VI nIl 
1 -07 ...os -14 -1S .. 31 
-3' 1 • 
.2 .. IS) 52 .. 2S -38 .. \4 02 -18 
3 -30 30 .... 3 -4t OS OS 21t ,. 
-$4 42 -31 .. itS 29 10 Olt 
S -20 53 68 ... 10 .07 ....ot 15 
6 -31 52 56 -01 -01 30 ...()6 
7 -29 60 It2 -IS ... 32 -12 -0. 
I .. 6' 32 -02 22 30 -37 -01 
9 -01 66 19 ... 01 !S -13 lit 
10 83 31 -05 32 12 -61 15 
11 88 -18 0) -18 08 ..()6 06 
12 83 
" 
-2. l2 ... OS .. 05 -OS 
13 93 -10 n -29 -ol -OS ....c.l4 
lit 7t ItS -32 14 -11 -0.\ -lit 
15 88 -18 20 ... 21t UJ -15 -11 
16 16 lM) -05 25 -03 09 05 
17 9O ... 22 17 .. u 06 01 IS 
18 88 38 -17 08 -06 00 02 
19 91 -Ut 20 -29 03 09 
" 20 16 • 3 -I • 13 -0. O. OIl 
21 87 -21 26 .. 21 1" ...0. -07 
........ r 1 r ",n I • 
, . 
Note:.-J)&c1a61 place~ have beeD .ittcd. 
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Table 16 
Unrotated Principal Axes 'actor Solution 
for Atropine Condition 
"actor 
Variable 
1 II III IV V VI 
1 -58 -02 -22 00 -30 -17 
2 18 63 -30 07 13 16 
3 -1. 47 -81 21 01 04 
4 -25 54 -64 30 -15 05 
5 -12 59 54 25 -32 07 , 
-16 SS 55 38 -22 10 
7 -04 50 08 -40 -45 04 
8 ... 02 53 -03 63 -13 05 , 07 45 -06 -39 08 -40 
10 77 44 13 25 26 -10 
11 83 0" -02 3' -22 -29 12 96 20 03 -05 18 -03 
13 92 -16 -10 03 
-2" -16 
14 93 24 03 -19 06 -0. 
15 81 -30 -15 -18 -33 OS 
16 94 23 10 -03 20 02 
17 90 -20 -04 22 -16 -10 
18 9. 23 01 -01 I" 15 
19 92 -23 -10 05 -20 02 
20 94 15 -02 -08 08 IS 
21 15 
-44 ... 19 -OS -21 27 
Note.-Deoimal places have been o.itted. 
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Table 17 
Unrotated Principal Axes 'actor Solution 
for Dexedrine Qondition 
Pac:!tor 
Variable 
I II III IV V VI 
1 -04 00 29 -23 -62 11 
2 02 68 -10 14 17 23 
3 -14 76 03 -40 14 -28 
4 -24 82 26 -19 13 -08 
5 -25 -32 72 -21 15 13 
6 -25 -28 77 -20 11 -20 
7 23 31 32 30 -20 26 
S -19 32 38 16 -49 -10 
9 -46 22 44 11 05 42 
10 80 -08 38 21 30 03 
11 92 .. 14 15 -19 07 -12 
12 88 12 21 22 13 11 
13 96 00 06 -20 00 08 
14 92 14 19 23 00 -05 
15 87 08 -06 -33 -02 23 
I' 9S -04 14 21 OS -08 
11 95 -16 -01 -23 -06 -04 
18 97 11 00 13 -10 ... 03 
19 94 03 -12 -20 -11 -04 
20 97 08 -02 13 -12 -10 
21 81 11 -21 -28 -02 21 
Note.-Decima1 places have been omitted. 
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Tat.le 18 
Unrotated Principal Axes Factor Solution 
for Chlorpromaaine Condition 
Factor 
Variable 
I II III IV V VI VII 
1 -17 50 -18 -42 -32 -30 -12 
2 -23 35 56 32 -10 12 -10 
3 -56 27 65 -17 06 -05 IS 
... 
-66 19 64 05 18 -08 08 
5 -64 06 -26 56 -14 -06 13 
6 -64 16 -46 40 -24 -04 11 
7 -38 52 17 09 -39 -26 -15 
8 -51 03 -29 -11 48 -10 12 
9 -38 06 06 67 19 -21 -09 
10 13 46 -03 23 07 32 -14 
11 90 -10 18 06 -29 09 04 
12 78 ~ 00 17 33 -13 -10 
13 9S -21 OS 02 -15 -08 07 
14 79 43 -14 -06 15 -29 -14 
15 78 -49 14 12 11 -24 -04 
16 81 42 -06 11 09 24 11 
11 88 -19 12 12 -:n 01 11 
18 16 63 -06 -OS 10 -02 12 
19 91 -27 09 12 -18 
-11 06 
20 77 60 -08 -OS 03 -02 10 
21 16 
-51 13 14 22 
-18 06 
Note.-Decimal places have been omitted. 
9S 
Table 19 
Unrotated Principal Axes Factor Solution 
for Physostigmine CODdition 
Factor 
Variable 
1 II III tv V VI 
1 -06 -03 01 IS 40 23 
2 10 37 -38 -20 10 34 
3 -18 5S -71 23 14 03 
4 -21 75 
-" 28 -17 -04 
S -20 30 49 ,.,9 -15 20 
6 -04 43 63 22 -13 23 
7 19 69 -07 01 17 -19 
8 16 34 38 -06 -01 -22 
9 05 64 29 10 10 -25 
10 88 06 32 -13 21 -01 
11 90 01 24 OS 21 03 
12 94 02 -06 -13 05 -11 
13 96 -06 00 10 07 -OS 
14 94 22 -02 -15 -08 06 
15 87 -14 -11 32 -04 
-15 
16 93 25 01 
-15 -11 09 
17 87 -22 -09 32 18 09 
18 89 26 -02 
-22 -26 08 
19 83 -24 -21 36 -12 04 
20 89 20 -12 33 -11 12 
21 78 -42 
-16 32 -14 -08 
Note.-Decimal places have been omitted. 
96 
Table 20 
Pinal Transformation Matrix 
for Normal Condition 
It. B C D E r 
I 36 04 42 -08 -02 -04 
11 -17 54 46 49 13 -12 
III -68 -19 6S -23 -03 12 
IV -10 42 -08 -76 43 -06 
V -12 -66 39 12 S9 ... 42 
VI 60 -24 -19 33 67 89 
Note.-De.cimal place. have been omitted. 
Table 21 
Pinal Transformation Matrix 
for Placebo Condition 
A B C D E r G 
1 -06 31 -02 33 -61 01 -64 
11 2S 58 42 -20 09 16 09 
III -38 -37 66 33 -01 10 -06 
IV -65 51 -21 -72 -OS 10 -25 
V 30 -23 -15 43 -64 59 -11 
VI 43 26 0' -23 -61 -77 -21 
VII 30 10 56 03 38 10 -93 
Note.-Decimal places have been omitted. 
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Table 22 
Pinal Tran.formation Matrix 
for Atropine Condition 
A B C D E P 
I 37 ...04 -05 03 38 01 
II 34 29 42 34 -18 02 
III 10 49 -76 ...01 -13 03 
IV -06 31 3S -76 04 35 
V 72 -57 -06 -33 -89 28 
VI 47 46 34 -4S -13 -89 
Note.-Decimal places have been omitted. 
Table 23 
Pinal Transformation Matrix 
for Dexedrine Condition 
A B C D E F 
I 88 -04 -04 04 -01 03 
II 16 74 -26 -03 16 27 
III 40 13 71 -18 22 22 
IV 04 -36 -31 -77 01 33 
V 04 26 42 -37 -96 20 
VI 21 -49 28 49 ...06 8S 
Nota.-Deeimal places b.ave been omitted. 
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Table 24 
,inal Trausformation Matrix 
for Chlorpromazine Condition 
A B C D E , G 
1 33 29 -13 -12 ... 02 -01 -04 
II -28 68 22 08 -09 21 -05 
III 31 -20 16 -21 00 -03 15 
IV 23 19 11 60 16 -25 22 
V -39 59 01 -22 58 -56 -04 
VI -59 18 -21 -39 ... 60 -66 21 
VII 41 03 53 60 -51 -38 -94 
Note.-Decimal places have been omitted 
Table. 25 
Final Transformation Matrix 
'or Physostigmine Condition 
A B C 0 E P 
I 35 -as -02 37 09 00 
II 27 48 21 -16 44 -07 
III -03 -62 41 -14 18 13 
IV -58 31 48 85 -04 -14 
V -44 37 -41 30 45 89 
VI 52 38 52 -04 -75 40 
Note.-Decimal places have been omitted. 
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Table 26 
Matrix of Cosines of Reference Vectors 
for N.9t'If.81 Condition 
A B C D E F 
A 1.01 
B 
-
.06 1.00 
C - .52 - .10 1.00 
D .30 - .17 .09 1.00 
E .28 
- .29 .10 .04 1.00 
F .51 
-
.05 - .32 .21 .30 1.00 
Table 27 
Matrix of Cosines of Reference V~ctors 
for Placebo Condition 
A B C D 'r F G .., 
A 1.00 
B .00 1.00 
C .15 .00 1.00 
D .31 
-
.64 .21 1.01 
Ii: - .31 .04 .29 - .10 1.01 
., 
- .19 
-
.22 .01 .37 .18 1.00 
G - .19 - .19 - .47 .10 - .12 - .01 1.00 
A 1.01 
B 
-
.OS 
C .14 
0 
-
.28 
E 
-
.64 
p 
-
.22 
A 
A 1.01 
B .03 
C .29 
D 
-
.05 
E .OS 
p 
.36 
Table 28 
Matrix of Cosines of Re:ference Vectors 
for Atropine Condition 
B C D E 
1.00 
.01 1.00 
-
.21 
-
.25 1.01 
.33 .03 .27 1.00 
-
.42 
- .21 .05 - .12 
Table 2:;' 
Matrix of Cosines of Reference Vectors 
for Dexedrine Condition 
B C D E 
LOa 
-
.en 1.01 
-
.10 .09 1.00 
-
.08 
-
.2' .27 1.00 
-
.26 .32 .04 - .15 
100 
p 
.99 
.99 
A 
It, 1.00 
B 
-
.44 
C .48 
D .57 
I .. .03 
F .32 
G .. .40 
A 
It, 1.00 
B - .01 
C .25 
D 
-
.56 
I .42 
., 
.13 
Table 30 
Matrix of Cosines of Reference Vectors 
for Chlorpromazine Condition 
B C D E 
1.0e 
.01 1.00 
-
.01 .36 .99 
.18 
-
.09 .. .11 ,99 
-
.36 - • 12 .03 .21 
-
.05 
-
.40 
-
.54 .37 
Table 31 
Matrix of Cosines of Reference Vectors 
for Physostigmine Condition 
B c D E 
.99 
- .02 .99 
.35 .14 1.00 
- .04 - .45 .07 1.00 
.32 
-
.23 .12 .10 
101 
G 
LOG 
.17 1.00 
F 
1.00 
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Table 32 
Ptaal Rotated Oblique Pactor &olutioa 
for Noru.l Conditt_ 
Pactor 
VarIable 
A It C J) I P 
1 -0, 00 01 01 en 55 
2 'I 22 02 5' 12 .... 9 3 ... 9 -06 01 82 -18 -13 
• 15 .. -06 86 11 13 5 0' 7' 01 81 10 -05 
6 -02 66 ... -06 2" -02 
1 -07 64 05 32 .. 28 
-I" 
I -15 -03 -08 -05 54 18 
9 00 05 06 04 5' ... 21 
10 00 33 68 .. en ...0, -11 • 
11 
'" 
29 -oIt ... 2 -18 1. 
12 02 Of 77 ,. 15 0,. 
13 69 05 -03 .. 6 01 11 
1" 01 05 7. en 07 0,. 
15 65 ..... -en -06 17 -13 
16 -05 06 7' -02 04 -2' 
17 56 11 ., 05 -18 -0" 
18 OJ -01 77 07 05 -10 
19 7. -oa 01 o. 0' 10 
20 01 ..07 77 07 o. 00 
21 6It. -14 01 -02 13 -12 
Mote.-Deciaal place. uve been CIIlitte4. 
Variable 
.It. 
1 -07 
2 4G 
3 16 
4 69 
5 -06 , 05 
7 00 
8 -11 
9 20 
10 -08 
11 02 
12 02 
13 03 
14 01 
15 -09 
16 -65 
17 02 
18 04 
19 08 
20 05 
21 -04 
Table 33 
Pinal Rotated Oblique Factor Solution 
tor Placebo Condition 
Factor 
B c D B 
-01 03 -02 54 
15 06 -04 97 
07 -05 00 10 
-10 06 06 -17 
-06 78 12 21 
04 61 -08 -17 
-01 58 -01 32 
-11 -02 -23 06 
18 1&2 10 -03 
65 08 03 -01 
08 -02 52 00 
72 -03 00 08 
08 05 58 02 
74 -13 -08 07 
-06 -05 64 -07 
14 11 -03 -en 
05 12 56 -01 
67 03 07 07 
04 13 60 -07 
74 07 00 05 
-10 05 69 -8S 
Note.-Dectmal places have been omitted. 
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P G 
00 -02 
-10 39 
-06 -04 
09 12 
18 -09 
-11 02 
00 27 
52 13 
45 -10 
18 -27 
06 -07 
01 06 
00 08 
01 16 
16 21 
01 -14 
02 -1.9 
03 -03 
-07 -08 
-02 -07 
11 07 
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Table 34 
Pinal Rotated Oblique Pactor Solution 
for Atropine Condition 
Pact or 
!Variallie 
A B C D B P 
1 -54 00 15 15 10 05 
2 42 05 55 06 -14 -08 
3 03 -17 91 -02 -OS 03 
4 -08 08 85 -02 03 01 
5 00 75 -03 08 06 -04 
6 OS 74 00 -08 -03 01 
7 -12 31 05 60 27 -29 
8 14 01 05 68 -01 -30 
9 07 -21 -04 60 -08 24 
10 57 06 08 -05 -01 27 
11 00 10 03 -03 56 33 
12 54 -10 -03 09 17 07 
13 03 -06 -06 11 63 09 
14 46 -09 -06 26 25 02 
15 -01 -04 -07 13 66 -22 I' 59 -04 -04 05 12 OS 17 08 01 -04 -11 54 13 
18 61 03 02 04 16 -10 
19 11 -01 -03 -03 59 -06 
20 53 -01 05 ···0.4 24 -13 
21 09 -03 01 -14 54 -32 
Note.-Dee1mal places b.ave been emitted. 
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Table 3S 
Pinal Rotated Oblique Pactor Solution 
tor Dexedrine Condition 
Pact or 
Variable 
A B C D I II' 
1 07 -09 01 41 65 -OS 
2 15 37 ... 16 -06 -09 44 
3 -06 89 -01 09 81 -14 
4 00 79 09 00 07 16 
5 04 -06 83 11 .OS 12 
6 00 10 73 -11 03 -13 
7 44 -03 OS -11 30 44 
8 00 16 -01 -06 62 03 
9 -10 00 41 04 07 54 
10 87 -05 35 -36 -22 24 
11 82 03 17 00 -06 -13 
12 94 -01 l' -26 -06 31 13 88 00 09 14 00 04 
14 91 03 -01 -27 06 lit· 
15 79 02 OS 35 -01 12 
16 88 -09 00 ... 32 -02 08 
17 19 -01 03 15 02 -14 
18 86 -02 -16 -12 10 05 
19 17 03 -13 15 07 -11 
20 84 -01 -20 -14 12 -02 
21 73 01 -09 33 -04 09 
Note.-Decimal places have been omitted. 
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Table 36 
Final Rotated Oblique Factor Solution 
for Chlorpromasine Condition 
'actor 
Variable 
It. B C D B P G 
1 -10 00 -10 -03 -06 64 ... 07 
2 00 08 51 04 -05 -01 27 
3 -03 -11 69 -05 -05 03 ... 09 
4 -06 -08 69 03 12 -07 02 
5 -03 -07 01 62 -01 -05 -02 
6 -14 -05 -11 56 ... 10 07 -07 
7 05 -06 26 20 -02 53 14 
8 -38 18 -OS 06 27 -20 -20 
9 OS 12 23 43 39 -08 20 
IG -12 67 -11 -13 -10 -17 19 
11 47 01 -02 -07 -24 04 00 
12 08 73 02 -G4 29 -02 04 
13 54 02 -os -03 -07 04 -08 
14 14 57 -12 -07 27 26 -02 
15 55 -09 -05 -04 28 -03 02 
16 04 67 -02 01 -17 -21 -08 
17 57 -05 -01 05 -22 04 -07 
18 07 71 06 00 -07 OS -20 
19 63 -05 -03 07 -01 09 -07 
20 09 65 02 -02 -10 10 -19 
21 51 -02 00 -01 26 -18 -06 
Note.-Decimal places have been omitted. 
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Table 31 
Pinal Rotated Oblique Factor Solution 
for Physostigmine Condition 
Pact or 
Variable 
A B C D E P 
1 -18 23 03 21 00 44 
2 39 S2 -01 -12 -OS 18 
3 -08 84 -15 18 13 ... 03 
4 03 65 15 OS 18 -32 
5 -12 02 70 11 -03 -08 
6 13 -07 67 -03 06 00 
7 08 36 -06 03 S2 02 
8 07 -19 11 -10 39 -06 
9 -04 10 14 00 51 -04 
10 29 -18 01 23 27 23 
11 19 -04 02 41 25 27 
12 33 -06 -19 26 19 01 
13 21 -04 -05 47 12 03 
11' SS 02 02 16 11 -05 
15 03 ... 01 -01 62 08 -14 
16 51 -02 10 13 09 -04 
17 03 10 01 69 -04 15 
18 66 -OS 08 02 03 -19 
19 10 06 09 65 -17 -16 
20 61 03 -08 -01 02 -03 
21 00 -13 00 61 -17 -20 
Note.-Decimal plaees have been omitted. 
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Table 38 
Means for All Variables 
in Six Conditions 
Condition 
Variable Nonw.l Placebo Atropine Dexedrine Ch1orpro- Physostig-
mazine mine 
1 199.30 195.20 199.65 191.60 185.35 196.10 
2 22.95 22.70 22.45 23.30 22.10 23.05 
3 14.25 14.35 15.00 13.95 13.70 14.55 
4 19.05 19.15 19.60 19.20 18.SO 19.10 
5 45.45 45.35 44.55 44.35 43.85 43.30 
6 61.55 66.30 66.15 67.70 68.25 66.65 
7 43.60 47.10 44.25 48.05 45.85 44.30 
8 39.00 39.25 38.60 39.25 31.45 39.95 
9 136.85 135.30 135.70 133.00 130.70 135.75 
10 1.60 7.42 7.88 7.55 1.81 7.75 
11 IS.79 14.53 15.27 14.90 16.74 15.81 
12 15.18 15.37 16.30 15.46 16.54 15.72 
13 15.81 14.92 15.40 15.14 16.71 15.91 
14 22.39 22.83 24.76 22.56 24.21 22.86 
15 16.80 16.74 17.78 16.12 18.24 17.35 
16 7.50 7.56 1.96 7.94 1." 1,lS2 
11 16.18 15.21 15.24 15.90 11.68 15.85 
18 15.22 14.95 16.15 15.57 16.08 15.89 
19 15.47 14.66 15.32 15.55 17.51 15.02 
20 22.49 21.88 23.30 22.88 24.02 22.85 
21 16.21 15.93 16.41 16.58 18.21 16.36 
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Table 39 
Standard Deviations for All Variables 
in Six Conditions 
Condition 
Variable Normal Plaeebo Atropine Dexedrine Chlorpro- Phys08tig-
maeine mine 
1 43.62 43.86 41.54 57.27 45.56 41.06 
2 3.17 3.40 2.10 2.36 2.34 2.50 
3 4.49 3.65 4.18 3.49 4.40 3.86 
4 3.16 3.43 3.63 3.64 4.60 3.66 
5 14.50 14.81 16.36 16.33 15.23 12.94 
6 32.66 33.39 32.01 29.32 32.14 29.97 
7 11.55 10.87 8.32 12.12 15.25 13.62 
8 16.22 14.03 10.82 12.48 13.96 11.54 
9 38.49 41.94 36.84 45.20 44.18 41.64 
10 2.41 2.18 2.57 2.08 2.03 2.60 
11 6.29 4.95 5.14 5.17 6.33 5.13 
12 4.76 4.65 5.22 4.40 4.33 4.94 
13 5.38 5.64 5.01 4.87 6.33 5.19 
14 7.17 7.73 8.53 6.73 7.80 1.94 
15 7.00 6.94 6.77 6.S0 7.19 5.12 
16 2.15 2.20 2.53 2.04 1.90 2.44-
11 6.81 6.15 5.35 5.94 6.98 5.51 
18 4.26 4.12 5.08 4.41 4.1S 4.46 
19 6.0S 6.05 5.35 6.06 7.10 4.27 
20 5.84 5.81 6.82 6.92 7.01 6.49 
21 6.77 6.10 5.32 6.56 8.51 4.12 
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